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ABSTRACT
Japanese encephalitis (JE) is a major cause of childhood mortality and 
morbidity in Asia and for which there is no treatment. In addition to direct 
viral cytopathology, a poorly regulated inflammatory response is postulated 
to contribute to the pathogenesis, possibly through bystander death of 
uninfected neurons; but there have been few studies examining this. We 
used a validated macaque model of JE to characterize the inflammatory 
response and cytopathic effects of JE virus (JEV) in the brain. There was 
strong perivascular infiltration of leukocytes, particularly T cells, with 
endothelial cell activation, vascular damage and leakage of serum across 
the blood brain barrier (BBB). Adjacent parenchyma exhibited macrophage 
rich infiltrates, with astrocyte and microglia activation. JEV antigen was 
seen mostly in neurons, but there was no correlation between intensity of 
viral infection and degree of inflammatory response. Apoptotic cell death 
was seen in both infected and non-infected neurons. Interferon (IFN)-a, 
which is a microglial activator, was also expressed by both. Tumour 
necrosis factor-a (which can induce neuronal apoptosis), inducible nitric 
oxide synthase and nitrotyrosine (involved in nitric oxide production) was 
expressed by microglial cells, astrocytes and to some extent macrophages. 
The same cells expressed matrix metalloproteinase (MMP)-2 whilst MMP-9
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was expressed by neurons; both MMPs cause BBB disruption. The results 
are consistent with JEV inducing neuronal apoptotic death and release of 
cytokines such as IFN-a; these are postulated to initiate microglial 
activation, and release of pro-inflammatory and apoptotic mediators with 
subsequent apoptotic death of both infected and uninfected bystander 
neurons. Activation of astrocytes, microglial and endothelial cells likely 
contributes to inflammatory cell recruitment and BBB breakdown. These 
results provide strong evidence that neuronal apoptotic death and 
activation of microglial cells and astrocytes play a crucial role in the 
pathogensis of JE, and suggest new paths for targeted therapies.
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CHAPTER 1
INTRODUCTION
1.1 Japanese encephalitis overview
Japanese encephalitis virus (JEV) continues to be the leading cause of 
viral encephalitis in Asia and the Western Pacific, where it is a significant 
cause of mortality and disability (Solomon, 2006). Annually there are 
estimated 35,000-50,000 cases world-wide with 10,000-15,000 deaths 
(Solomon et al., 2003). Approximately one third of patients die, and half of 
the survivors have severe neuropshychiatric sequelae. A renewed concern 
for the disease followed the outbreak of JE in India in 2005 with more than 
1000 fatalities (Kumar et al., 2006). Although vaccination is the most viable 
option to prevent the disease, affordable vaccines are still not widely 
available (Beasley et al., 2008), and there is no established treatment for 
JE.
1.2 Historical perspective
Epidemics of encephalitis were described in Japan since from the 1980s 
(Innis, 1995). Major epidemics were reported approximately every ten 
years, with more than 6000 cases reported in the 1924 epidemic (Miyake,
21
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1964). JEV was isolated in 1934 from the brain of a fatal case of 
encephalitis (Monath, 1988) and this virus isolate was characterized as the 
prototype (Nakayama) strain of JE virus. The virus was later classed as a 
member of the genus flavivirus (Family Flaviviridae) named after the 
prototype yellow fever virus (in Latin yellow = flavi). Although of no 
taxonomic significance, the ecological term “arbovirus” is often used to 
describe the fact that JEV is insect (arthropod) borne.
1.3 Epidemiology
JE is a major public health problem in several parts of Asia particularly 
China, India, Nepal, Sri Lanka, Vietnam, Cambodia and Thailand. JE is 
also reported from other Asian countries such as Indonesia, Malaysia, 
Myanmar, Philippines, Republic of Korea and Japan albeit to a lesser 
extent. It is predominantly reported from rural areas, especially among the 
lower socio-economic groups. JE exhibits a seasonal pattern with 
incidence of disease peaking during or shortly after the rainy season. 
However, variations within the same region are known. For instance, 
epidemics occur during or soon after rainy seasons in the northern regions 
of Vietnam and Thailand, while the disease has been reported throughout 
the year in the southern parts of these countries (Umenai et al., 1985).
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The epidemiology of JE has undergone a remarkable change in recent 
years and it is emerging in many new geographic regions of Asia. Until a 
decade ago Indonesia was the southern limit for JE while the Eastern 
States of India were the western limit. JE has now emerged in some 
countries beyond these limits; consequently the geographic boundaries 
have now extended to Pakistan in the West (Igarashi et al., 1994) and 
Australia in the South (Hanna et al., 1996) (Figure 1.1).
Figure 1.1 Global distribution of Japanese encephalitis (http://www.phac- 
aspc.gc.ca/publicat/ccdr-rmtc/11vol37/acs-1/index-eng.php)
1.4 Transmission cycle of Japanese encephalitis
JEV is zoonotic and transmitted naturally between wild and domestic birds,
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and pigs by Culex mosquitoes - the most competent vector for human 
infection being Culex tritaeniorhynchus (Figure 1.2). All Culex species are 
zoophilic, preferring to feed on animals and birds to humans.
Environmental temperature and available pools of water as created in rice 
fields in most of Asia provide an ideal environment for vector replication 
and virus replication in the mosquito host. Although many animals can be 
infected with JEV, only those which develop high viraemias are important 
in the natural transmission cycle. Birds are the most important vertebrate 
host in maintaining the virus. As well as maintaining and amplifying JEV in 
the environment, birds may also be responsible for the spread of JEV to 
new geographical areas (Paul et al., 1993). Pigs act as important 
amplifying hosts in the transmission of JEV to humans. They are often kept 
close to human dwellings, have prolonged and high viraemias, and 
produce many offspring - thus providing a continuous supply of previously 
uninfected hosts. Humans become infected with JEV coincidentally when 
living or travelling in close proximity to the virus’ enzootic cycle. Although 
the virus has occasionally been isolated from human peripheral blood 
(Chan & Loh, 1966) viraemias are usually brief and titres low; thus humans 
are considered a dead end host from which transmission does not normally 
occur.
24
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Figure 1.2 Transmission cycle of Japanese encephalitis virus 
(http://infosehatbugar.blogspot.com/2009/06/penyakit-japanese-encephalitis.html)
1.5 Virology
In common with all flaviviruses, JEV has a small (50nm) lipoprotein 
envelope surrounding a nucleocapsid comprising of core protein and 11 KB 
single stranded RNA (3800 kD) (Figure 1.3A). At least five genotypes of 
JEV occur in Asia, which relate approximately to the geographical area of 
isolation (Chen et al., 1990, 1992).
Like the other flaviviruses, the JEV virion consists of a single strand of
25
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positive-sense RNA, wrapped in a nucleocapsid and surrounded by a 
glycoprotein containing envelope. The RNA comprises a short 5’ 
untranslated region (UTR), a longer 3’ UTR, and a single open reading 
frame between them. This codes for a single polyprotein which is co- and 
post-translational cleaved by viral and host proteases into three structural 
proteins (core-C, pre-membrane-PrM, and envelope-E), and seven 
nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) 
(Figure 1.3B).
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1.6 Clinical Features
Patients with JE typically present after a few days of non-specific febrile 
illness, which may include coryza, diarrhoea and rigors (Solomon et al., 
2000). This is followed by headache, vomiting and a reduced level of 
consciousness, often heralded by a convulsion. In some patients, 
particularly older children and adults, abnormal behaviour may be the only 
presenting feature, resulting in an initial diagnosis of mental illness. A 
proportion of JE patients make a rapid spontaneous recovery. Others may 
present with aseptic meningitis and have no encephalopathic features. 
Convulsions occur frequently in JE, though no association with outcome 
has been noted. The classical description of JE includes a dull flat ‘mask­
like’ facies with wide unblinking eyes, tremor, generalised hypertonia, 
cogwheel rigidity and other abnormalities of movement (Misra & Kalita, 
1997). Opisthotonus, and rigidity spasms, particularly on stimulation, occur 
in about 15% of patients and are associated with a poor prognosis (Kumar 
et al., 1990).
Approximately 30% of hospitalised patients with JE die, and around half 
the survivors have severe neurological sequelae. In areas with better 
hospital facilities there is a reduction in mortality, but a concomitant
28
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increase in the number of patients with sequelae (Ooi et a/., 2008). 
Approximately thirty percent of survivors have frank persistent motor 
deficits. These include a mixture of upper and lower motor neuron 
weakness, cerebellar and extrapyramidal signs. Fixed flexion deformities of 
the arms, and hyperextension of the legs with ‘equine feet’ are common. 
20% of patients have severe cognitive and language impairment, and 20% 
have further convulsions (Kumar et al., 1993). In addition, more detailed 
studies showed that there might be subtle sequelae such as learning 
difficulties, behavioural problems and subtle neurological signs (Kumar et 
al., 1993).
1.7 Laboratory assays for diagnosis of JE
1.7.1 Serology
For most practical purposes JE is diagnosed serologically. In the 1980s 
simple enzyme linked immunosorbant assays (ELISA) were developed and 
IgM antibody capture ELISA (MAC ELISA) for serum and CSF of patients 
within 4-7 days of onset of disease has become the accepted standard for 
diagnosis of JE (Innis, 1989). The haemagglutination inhibition test was 
used for many years, but it had various practical limitations, and since it 
required paired sera could not give an early diagnosis (Clark & Casals,
29
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1958).
1.7.2 Plaque Reduction Neutralization Titre Assay (PRNT)
This technique directly measures the infectivity of a virus preparation or 
stock as plaque forming units based on the finding that JE virus produces 
cytopathic effects (plaques) in certain cell lines. The endpoint is the titre of 
antibody that will reduce a certain percentage of viral plaques such as a 
50%, 70%, or 90% plaque reduction (PRNTso, PRNTto, PRNTqq 
respectively) compared to control cultures. PRNT5o is the most commonly 
used endpoint. Today a number of PRNT protocols are being used to 
measure JE neutralizing antibody using a variety of cell lines, including 
LLC-MK2, Vero, and BHK21 cells. In a patient with suspected acute JE 
infection, a titre increasing by fourfold suggests an acute infection. A titre of 
1:10 or more suggests past exposure or vaccination, and protective 
immunity.
1.7.3 Virus isolation
Even with the best laboratory facilities attempts to isolate JEV from clinical 
specimens are often unsuccessful because of low viral titres and the rapid 
production of neutralizing antibodies. JEV can be diagnosed by injecting 
post mortem brain tissue into cultured cells as it forms plaques in LLC-MK
30
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(rhesus monkey kidney) cells, vero (African kidney monkey green) cells, 
and BHK-21 (baby hamster kidney) cells, and in mosquito cell lines such 
as C6/36 line (Aedes albopictus mosquitoes) and LSTM AP-61 line (Aedes 
pseudoscutellaris mosquitoes). It was also shown that virus could also be 
isolated from cerebrospinal fluid (CSF) but it is slow and technically difficult 
(Leake et al., 1986).
1.7.4 Immunohistology
Immunohistological staining techniques of CSF cells or autopsy tissue with 
anti-JEV antibodies provide another way of detecting virus (Desai et al., 
1995; Mathur ef a/., 1990; Johnson etal., 1985; Myintef a/., 1994). The 
value of immunohistology is in diagnosing fatal cases of JE when sera or 
CSF are not available.
1.7.5 Molecular techniques
JEV ribonucleic acid (RNA) has been detected in human CSF samples 
using reverse transcriptase polymerase chain reaction (Igarashi et al., 
1994), however its reliability for regular diagnostic purposes has not been 
shown. Currently there is no simple rapid diagnostic test that is appropriate 
for use in the field.
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1.8 Pathogenesis of JE
The course and outcome of the disease is thought to be influenced by the 
dose, the route of inoculation, the species, the age of the host, immune 
sensitization by earlier infection by the same group of cross-reacting 
viruses in the endemic areas and the virulence of the virus. Host factors 
that affect the outcome include the immune status, reticuloendothelial 
clearance mechanism, nutritional status and probably genetic factors play 
a role.
Following the bite of an infected mosquito, JEV is thought to amplify 
peripherally, causing a transient viraemia before invading the central 
nervous system (CNS). Based on data from mouse and macaque monkey, 
the site of peripheral amplification is thought to be dermal tissue and then 
lymph nodes. WNV is reported to have a larger dermal cell reservoir in 
keratinocytes in mice (Lim et al., 2011). In mice, high rates of JEV 
replication within dendritic cells are linked to higher mortality (Wang & 
Deubel, 2011). After entering the body through a mosquito bite, the virus 
reaches the CNS via leukocytes (probably T lymphocytes); it is still not 
clear whether macrophages can also harbour JEV (Ghosh & Basu, 2009). 
The means by which JEV crosses the blood brain barrier (BBB) is not
32
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known but the presence of diffuse infection throughout the brain in humans 
indicate a haematogenous route of entry (Desai ef a/., 1995; Johnson et 
al., 1985). This was supported by an intranasal monkey challenge model, 
in which virus replication was widespread in the CNS and not always 
identified in the olfactory bulb (Myint et al., 1999; Raengsakulrach et al., 
1999). Whether the virus is passively transported, or actively replicates in 
the endothelium or within infected inflammatory cells that enter the brain 
parenchyma is unclear. Although experimental evidence suggests 
replication within endothelial cells may be an important means of crossing 
the blood brain barrier in some flaviviruses, for JEV passive transfer across 
the endothelial cells appears a more likely mechanism (Desai et al., 1995; 
Johnson et al., 1985). The neural invasion in humans is followed by 
perivascular cuffing, infiltration of inflammatory cells (T cells and 
macrophages) into the parenchyma, and phagocytosis of the infected cells. 
Phagocytic microglial cells remove degenerated neurons forming typical 
microglial nodules (Johnson etal., 1985; Miyake, 1964). Gliosis involving 
microglial cells and astrocytes is a common feature and microglial nodules 
are often in close proximity to the affected regions. Neuronal cells 
constitute the main cellular target population of JEV as in West Nile virus 
(WNV) and tick-borne encephalitis virus (TBEV).
33
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Electron microscopic studies of the brains of infected mice show that virus 
replicates in the rough endoplasmic reticulum and Golgi apparatus. There 
are hypertrophy of the endoplasmic reticulum and degeneration into cystic 
structures causing extensive cellular dysfunction (Hase etal., 1990).
Although a variety of animal model for JEV exists, the rodent models are 
the most characterized and a considerable knowledge regarding the 
pathogenesis has been generated from these studies. Basic histological 
findings in the CNS lesions in JEV-infected mice are similar to other 
f/av/V/rt/s-infected mice as well as that of humans. However some JEV 
infected mice have a prominent infiltration of CD8+ T cells compared to the 
human autopsy studies in which CD8+ cells are a minority among the T 
cell population (Johnson etal., 1995; Kimura et al., 2010). The rodent 
model has shown that activation of microglial cells may play a significant 
role in the pathogenesis by producing inflammatory mediators like 
inducible nitric oxide synthase (iNOS) and cytokines inducing neuronal 
death (Ghoshal et al., 2007). The rhesus macaque has been proposed as 
a potential model for the evaluation of vaccines and anti-viral treatments. 
The genome sequence of macaques and humans are 93% similar. The 
neuropathology of macaques intranasally inoculated with JEV resembles
34
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that of humans with encephalitis that results from naturally acquired 
infection (Myint et ai, 1999), whereas intradermal or subcutaneous 
inoculation of JEV in macaques generally results in asymptomatic infection 
(Morris et ai, 1955). The apoptosis pathways and the full spectrum of pro- 
inflammatory factors including matrix metalloproteinases (MMPs) have not 
been fully characterized apart from cytokines in any previous animal 
models or in autopsy tissues.
Despite the disease’s importance, little is known about the pathogenesis 
(Solomon & Vaughn, 2002). Infection, dysfunction and subsequent 
destruction of neurons are presumed to be the main cause of death in JE. 
Neuronal apoptosis is one of the hallmarks of neurodegenerative infections 
and 20 years ago was shown to be induced by JEV in an in vitro study 
(Hase et ai, 1990). However, its relevance for the disease and its 
mechanism are still unclear. In addition, the extent of cel! injury that occurs 
as a consequence of the inflammatory response, as opposed to direct viral 
cytopathology, is unknown.
35
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1.8 Aims
Because of cultural constraints in many of the areas where JE occurs, 
autopsy tissue from fatal human cases is not often available. Mouse 
models have shown that microglia! activation and subsequent release of 
pro-inflammatory mediators plays a role in neuronal death in JE (Ghoshal 
et ai, 2007; Das et al., 2008), but detailed studies on the role and 
mechanisms of apoptosis and the contribution of glial cells have not been 
reported. The macaque model of JE represents an especially appropriate 
model for the study of JE since the macaque immune system closely 
resembles that of humans (Myint et al., 1999).
The present study used material available from prior vaccine studies with 
the macaque model of JE to focus on the inflammatory response and 
cascade of events that leads to neuronal damage, i was especially 
interested in apoptotic pathways and inflammatory mediators because 
these may point the way to new targeted treatments to control the 
inflammatory damage, even in the absence of antiviral therapy.
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Specific aims and hypotheses
1. To identify the mechanisms of neuronal damage in JE by exploring 
the role of apoptosis.
2. To identify the predominant inflammatory factors, in particular the 
cytokines, MMPs and iNOS, involved in JE pathogenesis.
3. To identify the pathways of inflammatory network that leads to 
neuronal cell death.
Hypothesis 1: Neurons are the main targets of JEV.
Hypothesis 2: In addition to viral cytopathology, bystander effect 
contributes significantly to neuronal cell death.
Hypothesis 3: Neuronal apoptosis is the hallmark of JE and multiple 
apoptosis pathways are involved in JE.
Hypothesis 4: Pro-inflammatory mediators contribute to neuronal damage 
in JE pathogenesis.
Hypothesis 5: Non-neuronal cells and blood brain barrier dysfunction play 
important roles in the pathogenesis of JE.
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MATERIALS AND METHODS
2.1 Animals
This study was performed on archived paraffin embedded brain tissue of 
twelve rhesus macaques {Macaca mulatta) challenged intranasally with a 
well characterized JEV strain (KE93) as part of an effort to evaluate 
second-generation JEV vaccines (Myint etal., 1999). Healthy, young adult 
macaques of both sexes, weighing 2 - 8 Kg were used for the original 
challenge study. All animals were bred at AFRIMS veterinary laboratory 
and the principles of good laboratory animal care were followed throughout 
the study.
The challenge study had been undertaken in several phases and with 
different doses (Table 2.1; Raengsakulrach etal., 1999). Animals were 
screened for neutralizing antibodies to dengue and JE and were found to 
be seronegative. After challenge, animals inoculated were observed daily 
for clinical signs of neurological illness. The monkeys were euthanized at 
the onset of stupor or coma (11-14 days post inoculation). JEV infection 
was confirmed by virus isolation from the brain; in all cases this was
38
Materials and Methods
supported by detection of igM to JEV in serum or CSF using the double 
sandwich capture MAC ELISA assay, or an increase in the 
haemagglutination inhibiting antibody to JEV (Raengsakulrach et al.,
1999). Five uninfected control monkeys from an unrelated study served as 
negative controls for histopathological and immunohistological 
examinations. All archived specimens used for this study are from 
unvaccinated monkeys.
Animal models of JEV have the advantage of being more readily available 
for optimization of tissue procurement and preparation, variables which are 
inherently difficult to optimize in human post-mortem studies. In conducting 
the original challenge studies, the investigators adhered to the Guide for 
the Care and Use of Laboratory Animals, as promulgated by the 
Institutional Animal Care and Use Committee. My re-use of the archived 
tissues for these new pathogenesis studies is in keeping with the 3Rs 
principle of Replacement, Reduction, and Refinement (Zurlo etal., 1996).
Challenge virus
The wild-type JEV (KE-93) was isolated from the brain of a 6 year old Thai 
male who died of encephalitis in Kamphaeng Phet, Thailand in 1983. Two
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monkeys (animals 1 and 2) were inoculated with a virus originally isolated 
in AP-61 cells and passaged once in C6/36 cells. The remaining 10 
monkeys received an isolate prepared from the brain of monkey number 2 
(DA 349) that was subsequently passaged twice in suckling mice to 
increase both virus titre and virulence. Virus titration was performed in 
Toxorrhynohites splendens mosquitoes.
Clinical manifestations in macaques
Clinical signs appeared approximately 7-10 days post inoculation. Early 
signs included localized mild muscle tremors and fasciculations, usually on 
the head and arms. The tremors steadily progressed and became more 
pronounced. While initially able to eat, the animals became progressively 
more anoretic and lethargic 2-4 days following initial signs. As time 
continued, the animals would lie in their cages and eventually become 
comatose and un-responsive.
2.2 Histopathology
Immediately after death, brains from all 12 infected animals and the control 
monkeys were exenterated and sections of frontal lobe, thalamus, 
brainstem and cerebellum were prepared and fixed in 10% neutral buffered
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formalin for at least 72 hours and processed according to standard 
histological methods. Following routine paraffin wax embedding, 3-5 pm 
sections were prepared and stained with haematoxylin-eosin (H-E) or used 
for immunohistology.
2.3 Immunohistology
For immunohistological studies, sections of thalamus and brainstem were 
selected as they had previously been shown to be heavily infected by JEV 
(Myint et al., 1999) and exhibited the most consistent histological changes. 
The cortex was chosen as a comparison tissue because it exhibited 
minimal parenchymal inflammatory infiltrates.
Selected sections of the brainstem and thalamus of each animal were 
stained for the presence of JEV antigen, apoptosis and apoptotic 
pathways, glial and inflammatory cells, von Willebrand Factor (to confirm 
BBB breakdown, through the demonstration of plasma protein leakage), 
and pro-inflammatory markers. Details on the panel of antibodies and the 
detection methods used are provided in Table 2.2. Briefly, sections were 
dewaxed in xylene and hydrated through graded alcohols. To inhibit 
endogenous peroxidase activity, they were treated with freshly prepared
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3% H2O2 for 15 min and washed three times with distilled water. Sections 
were then processed according to heat-induced epitope/antigen retrieval 
(HIER) protocols. This was followed by incubations with normal serum to 
block non-specific binding sites in tissues, and the primary antibodies (IS­
IS hrs at 4°C) at the optimized dilutions (Table 2.2). Optimal conditions for 
antigen retrieval and antibody dilutions (Table 2.2) were independently 
determined by comparative titration experiments.
Controls
Appropriate controls were included in parallel for each marker: uninfected 
control monkey brains as negative controls for JEV and to establish 
constitutive expression of other markers, positive controls (sections with 
known positivity for the specific marker), and isotype controls (in which the 
primary antibody was substituted with equal concentration of normal 
mouse/rabbit IgG) as negative controls.
2.4 Heat-induced epitope/antigen retrieval (HIER)
Formalin is a commonly used fixative for tissue preparation in pathology 
laboratories. A major adverse effect of this fixative is the concealing of 
tissue antigens by protein cross-linking (Shigeki etal,, 2005). Masking of
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epitopes is compounded in archival, paraffin-embedded specimens, which 
causes considerable loss of immunoreactivity. Pre-treatment with high 
temperature heating is the most important factor for retrieval of antigens 
concealed by formalin fixation in archived tissues. HIER is based on the 
principle that the combination of heat and pH can restore antigenicity to 
protein epitopes (Shi et al., 2001). The retrieval methods included 
treatment with microwaves, pressure cooker, and combined action of 
enzyme digestion and microwaves using solutions like citrate buffer, Tris 
HCI and EDTA.
In this study HIER was performed almost exclusively with a laboratory 
pressure cooker (Decloaking Chamber, Biocare Medical, Concord, USA) 
after the preliminary data which demonstrated that it produced the most 
consistent results compared to microwaving, enzyme digestion or a 
common pressure cooker. An advantage of the laboratory pressure cooker 
is that, temperatures of 120°C or higher (superheating) can be achieved. 
Other advantages include short duration of heating, and better 
reproducibility of results with large batches of slides. For comparison 
purpose a panel of retrieval solutions were tested for the respective 
antigens using serial sections from the same blocks; including citrate buffer
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pH 6 and pH 9, 0.05% citraconic anhydride solution pH 7 (Tokyo Kasei Co. 
Ltd., Tokyo, Japan) and Trilogy (Cell Marque, Hot Springs, USA). In all 
instances I have demonstrated that the combination of citrate buffer pH 6.0 
and the laboratory pressure cooker restores the immunostaining of a wide 
variety of antigens without affecting the tissue morphology.
2.5 Interobserver agreement
For each marker, the extent and intensity of the immunoreactivity was 
evaluated semi-quantitatively by two examiners independently (Khin Myint 
and Duangrat Mongkolsirichaikul). It was scored on a 4-point scale as 
follows: 0 = no difference from the negative control with regard to intensity, 
distribution and number of positive cells, or no positive reaction, 1+ = 
occasional individual positive cells, 2+ = a few nests of positive cells, 3+ = 
frequent positive cells in entire examined brain section. The results in 
agreement with two observers were considered as final. Identification of 
cell types based on morphological criteria and the mode of interpretation 
was confirmed by two pathologists (Anja Kipar and Yvonne Van Gessel).
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2.6 Confocal Microscopy
Confocal laser scanning microscope LSM 700 (Carl Zeiss Microimaging, 
Germany) with solid state lasers excitation wavelength 488 nm (for FITC) 
and 555 nm (for Texas Red) and ZEN 2009 software was used to detect 
immunofluorescent staining, while for all other light microsopic 
assessments, conventional microscopes were used. Confocal microscopy 
was kindly performed by Virachai Polsiri and Sansanee Noisakran of the 
Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 
Thailand.
2.7 Double immunolabelling
Dual staining was performed on selected sections of some monkeys 
(animals 2, 9, 11) to characterize the populations of cells expressing 
apoptosis markers (TUNEL and caspase-3, -8, and -9) and pro- 
inflammatory mediators (cytokines, iNOS and MMPs) and to relate them to 
the expression of JEV antigen. For this purpose, primary antibodies raised 
in different species were sequentially localized using non-overlapping 
secondary reagents and different chromogens (Table 2.3).
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2.8 Sequential staining
Sequential staining was performed on consecutive sections, mainly to 
detect tumour necrosis factor alpha (TNF-a) expression in inflammatory 
cells and glial cells and to further characterize JEV-infected cells when dual 
staining could not be attempted because the primary antibody was raised 
in the same species or when the double immunolabeling was difficult to 
interpret (Table 2.3).
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Materials and Methods
Table 2.3 Double and sequential immunostaining of Japanese encephalitis virus 
infected monkey brains
Antibody Detection Method 
(chromogen/fluorochrome)
First Second First Second
Double Immunostaining
TUNEL JEV IFA/FITC
IP/DAB
IFA/TR
ABC/AP
NeuN IP/DAB ABC/AP
CD68 IP/DAB ABC/AP
MAC387 IP/DAB ABC/AP
JEV GFAP IFA/FITC
ABC/AP
IFA/TR
IP/DAB
IFN-a ABC/AP IP/DAB
TNF-a ABC/AP IP/DAB
MM P-9 ABC/AP IP/DAB
iNOS ABC/AP IP/DAB
Cleaved Caspase-3 ABC/AP IP/DAB
Caspase-8 ABC/AP IP/DAB
Caspase-9 ABC/AP IP/DAB
BAX ABC/AP IP/DAB
CD68 iNOS ABC/AP IP/DAB
MM P-9 ABC/AP IP/DAB
TNF-a ABC/AP IP/DAB
Sequential Immunostaining
JEV CD68 IP/DAB IP/DAB
TNF-a GFAP IP/DAB IP/DAB
CDS I P/DAB IP/DAB
CD68 IP/DAB IP/DAB
IP/DAB = Indirect peroxidase with peroxidase-conjugated anti-mouse or-rabbit antibody 
(EnVision Systems; Dako, Carpinteria, CA) and diaminobenzindine (DAB, VECTOR, 
Burlingame, CA, USA) or NovaRED (VECTOR) as substrate
ABC/AP = Avidin Biotin Complex - Alkaline Phosphatase with 5-bromo-4-chloro-3-indolyl
phosphate/nitroblue tetrazolium (VECTOR Blue) as substrate
IFA/FITC = Indirect immunofluorescence with goat anti-rabbit FITC (kpl, Gaithersburg,
MD, USA) or sheep anti-mouse IgG FITC conjugate (Sigma, St. Louis, MO, USA)
IFA/TR = Indirect immunofluorescence with goat anti-rabbit Texas Red (Molecular Probes, 
Eugene, OR, USA) or goat anti-mouse Texas Red (Molecular Probes)
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Sources:
AFRIMS, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; 
Chemicon International, Inc, Temecula, CA, USA; DykoCytomation, Carpinteria, CA, USA; 
R&D, Minneapolis, MN, USA; Santa Cruz Biotecnology, Santa Cruz, CA, USA; 
Novocastra, New Castle, UK; Thermo Scientific, Rockford, IL, USA; Neo Marker, Fremont, 
CA, USA; AbCam, Cambridge, UK; PBL Biomedical Laboratories, Piscataway, NJ, USA.
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CHAPTER 3
HISTOPATHOLOGY, PHENOTYPING AND JEV TARGET
CELLS
3.1 Introduction
This chapter aims to examine the immune response and JEV targets in the 
brain of JEV infected monkeys.
3.1.1 Flavivirus encephalitis
In human autopsy studies the histopathological lesions in the brain showed 
variable degree of mononuclear cell infiltrate in the leptomeninges 
extending to the deep parenchyma, along the perivascular space. JEV 
induce neuroinflammation with features typical for viral encephalitides, 
including leptomeningitis, perivascular and parenchyma! infiltration of 
lymphocytes, and development of glial nodules associated with 
neuronophagia in regions of viral replication (Johnson et al., 1985). These 
lesions are consistently seen from the third day of illness and are 
commonly seen in the medulla oblongata, substantia nigra, thalamus, 
molecular layer of cerebellum and cerebral cortex. During the first few days 
of infection the brain shows a severe degree of vascular congestion and
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oedema. In patients who die rapidly from JE, there may be no histological 
sign of inflammation.
3.1.2 Rarefaction necrosis
The second most common characteristic microscopic finding of JE is the 
focal, discrete or confluent, small, round to oval areas of acellular necrosis 
described using a range of terms - rarefaction necrosis, ‘punched-out’ 
lesions (Desai et al., 1995; Johnson etal., 1985). Many of these are seen 
in abundance in the cerebral gray matter, thalamus, midbrain, pons, corpus 
striatum and medulla oblongata. These lesions are well circumscribed, 
pale, rarefied zones in the neuropil, usually around a capillary and are 
predominant after 2 weeks of illness.
3.1.3 Inflammatory cells
Several lines of investigation suggest that initial induction of the virus- 
specific T and B cell immune response is generated outside the CNS in 
peripheral lymphoid tissues. Activated cells leave primary lymphoid organs 
and travel through the blood to infiltrate CNS. Mononuclear inflammatory 
cells typically appear in three compartments: the CSF, the leptomeninges 
and the parenchyma of the brain and spinal cord. The types of cells
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making up the mononuclear inflammatory response have been 
characterized for JEV infection in humans (Johnson et al., 1985). The initial 
phases of inflammation are detectable at all sites 3-4 days after infection. 
The numbers of cells reach a maximum first in the CSF at 5-7 days. In the 
brain parenchyma, activated cells come from the blood and cross the 
cerebral vascular endothelium and accumulate in the perivascular space 
mostly T cells, B cells and macrophages. Sensitised T helper cells are 
presumably the first inflammatory cells to enter the brain, and their release 
of cytokines attracts macrophages (Johnson, 1971). Microglia and 
macrophages are thought to play an important role in the immune 
response in viral encephalitis (Erisi etal,, 1995).
Because of the inability to directly interact with infected neurons, T cells in 
the encephalitic brain are likely to influence the immune response and to 
produce their local effects by production of cytokines (Griffin, 1995). For 
many infections, CD8+ cytotoxic T cells (CTL) appear to be the primary 
mechanism for eliminating infected cells from the tissue site of replication. 
CTL recognize virus-infected target cells through presentation of virus 
peptides bound to major histocompatibility complex (MHC) molecules on 
the surface of the infected cell.
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B cells comprised 10% of the cells in the perivascular space, but not 
outside the perivascular regions (Johnson et al., 1985). Although B cell 
entry into the inflammatory response is generally slower, it is well 
documented that B cells produce antibodies against viral CNS infection 
and clear virus from the brain (Griffin, 2003; Tschen et a/.,2006). .
In animal models of JE, the cellular immune response appears to 
contribute to the prevention of disease during acute infection by restricting 
virus replication before the CNS is invaded. Athymic nude mice have 
increased susceptibility to experimental infection with JEV; transfer of 
spleen cells from mice immunized with live attenuated virus conveys 
immunity to infection (Jia & Huang, 1983). Spider monkeys, which are 
normally unaffected by intracerebrally inoculated JEV develop rapidly 
progressive encephalitis when T cell function has been impaired by 
cyclophosphamide (Nathanson & Cole, 1970). By analogy with other 
human viral infections, including influenza, HIV, Epstein-Barr virus and 
dengue, CTL might be important in the control and possibly clearance of 
JEV (Bukowski et al., 1989; McMichael, 1994). However, recent data from
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a mouse model suggested that CTL might be more pathogenic in JE 
infection (Larena et al., 2011).
3.1.4 JEV Target Cells
In human autopsy studies of JE fatalities many antigen bearing neurons 
are found to be relatively well preserved, the microglial cells forming 
satellites. In the acute phase a high density of JEV is seen in the neurons 
of hippocampus, thalamus, substantia nigra, inferior olivary nucleus, 
hypoglossal and vagal nuclei, while microglia are devoid of antigen 
(Johnson etal., 1985; Desai et al., 1995). In the later stages, with active 
neuronophagia, the viral antigen is largely confined to macrophages in 
microglial shrubs and perivascular zones. Very rarely JEV can be found in 
astrocytes, ependymal cell, or capillary endothelial cell (Johnson etal., 
1985; Desai et al., 1995). JEV antigen was not found in patients who died 
early in disease and for those who survived longer there was progressive 
clearance and was seen only in phagocytic cells (Johnson et al., 1985). 
The infection and destruction of neurons in brainstem can explain readily 
the profound coma and respiratory failure.
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3.2 Materials and Methods
Following routine paraffin wax embedding, 3-5 pm sections were prepared 
and stained with haematoxylin-eosin (H-E), inflammatory cell markers and 
JE antibody as specified in Table 2.2. With the exception of H-E, HIER was 
a requirement for all markers. Optimal conditions for antigen retrieval and 
antibody dilutions (Table 2.2) were independently determined by 
comparative titration experiments. The human CD8+ marker did network 
well with macaque tissue sections. Double immunostaining of JEV with 
glial fibrillary acidic protein (GFAP), apoptosis cell markers and pro- 
inflammatory markers; CD68 with pro-inflammatory markers, was 
performed as described in Chapter 2 (Table 2.3).
3.3 Results
3.3.1 Histopathology
All JEV-infected animals exhibited mild to moderate, multifocal to diffuse, 
non suppurative meningoencephalomyelitis with evidence of neuronal 
degeneration and death. The inflammatory changes in the macaques were 
localized largely to gray matter. The inflammatory response was dominated 
by perivascular cuffs comprised of lymphocytes and macrophages (Figure
3.1 A) and meningeal infiltrates predominantly lymphocytes. These were
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accompanied by morphological evidence of endothelial cell activation with 
occasional tombstone-like morphology (Kipar et al., 2005) (Figure 3.1 B) 
and/or vascular damage. The latter was indicated by perivascular 
haemorrhage and substantial leakage of serum into the parenchyma, as 
demonstrated by staining for von Willebrand factor (Figure 3.1 C). Neuronal 
cell death was indicated by morphological neuronal changes suggestive of 
apoptosis, in association with satellitosis or microglial nodules (Figure 
3.1D, E).
Reactive astrogliosis, represented by multifocal increase in astrocyte 
numbers (Figure 3.1 F) and evidence of astrocyte activation (presence of 
gemistocytes) in areas with inflammatory infiltrates was also identified.
3.3.2 Inflammatory cells
The inflammatory infiltrates were widespread throughout most sections. T 
cells (CD3+) were the predominant leukocytes in both perivascular and 
meningeal infiltrates. They were also present in small numbers in the 
adjacent parenchyma (Figure 3.2A). B cells (CD20+) were sparse and 
primarily seen in the perivascular infiltrates (Figure 3.2B), while moderate 
numbers of macrophage/microglial cells (CD68+) were identified in
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perivascular and meningeal infiltrates and the adjacent brain parenchyma 
(Figure 3.2C). With the CD68 reaction, positive plump-bodied cells 
appeared to be macrophages whereas ramified process-bearing small 
cells were in the form of microglial cells (Esiri et ai, 1995). Staining for 
myeloid/histiocyte antigen, reported to stain macrophages (Esiri & Morris, 
1991) and microglial cells (Foster ef a/, 2006), identified a substantial 
number of cells with a morphological appearance of macrophages (Figure 
3.2D), suggesting their recruitment into the tissue (Otani et al., 1999). 
Staining for CD68 and MHC class II antigen (expressed mainly by 
activated microglial cells) confirmed the presence of microglial nodules but 
also demonstrated activation of microglial cells (presence of both reactive 
and amoeboid microglial cells; Figure 3.2C.E) (Gonzalez-Scarano & 
Baltuch, 1999). Furthermore, endothelial cells were shown to express MHC 
II, suggesting their activation (Figure 3.2E inset; Washington et aL, 1994). 
The cells surrounding degenerating/dying neurons in satellitosis appeared 
to be CD68-positive microglial cells (Figure 3.2F). For comparison, in brain 
areas without evidence of viral antigen and inflammation (cerebral cortex), 
only scattered MHCM-positive microglial cells without morphological 
features of activation were seen. There was no evidence of inflammatory 
cells or microglial MHC II expression in control brains (Figure
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Appendix! 1). Semi-quantitative analysis of inflammatory cells was 
summarized in Table 3.!
3.3.3 JEV Target Cells
JEV antigen expression, seen as finely granular cytoplasmic staining, was 
observed in numerous neuronal cell bodies and processes disseminated in 
the thalamic and brain stem nuclei of all animals and in neuronal cell 
processes throughout the affected parenchyma (Figure 3.3A). Most 
infected neurons appeared morphologically unaltered (Figure 3.3A inset), 
but some were surrounded by microglial cells (satellitosis) and exhibited 
degenerative changes (Figure 3.3B). JEV-positive microglial cells were 
found in some microglial nodules, but occasionally also as individual cells 
in affected areas, as confirmed by sequential staining for CD68 and JEV 
antigen (Figure 3.3C). In contrast, there was no evidence of JEV infection 
of astrocytes (Figure 3.3D). In one animal with a particularly strong 
inflammatory response (animal 2), a small percentage of slender 
perivascular cells (perivascular macrophages) did also express viral 
antigen (Figure 3.3E). There was no evidence of JEV antigen in endothelial 
cells in any animal. Nor was there any association between intensity of 
viral infection and degree of inflammatory response. Negative control brain
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sections did not show any positive reaction. Semi-quantitative analysis of 
JEV antigen in the brain of monkeys following JEV infection was 
summarized in Table 3.1.
3.4 Discussion
My study has confirmed that as in humans, JEV induces a non-suppurative 
meningoencephalitis with neuronal cell death, microgliosis and astrogliosis 
(Akhter, 1999; Iwasaki et al., 1986; Johnson etai, 1985; Miyake, 1964); 
these are also common findings in other viral encephalitides (Leyssen et 
al., 2003).
However in my study the ‘punched-out’ areas as a result of focal acellular 
necrosis, which are often seen in fatal human JE cases (Desai et al., 1995; 
Johnson et al., 1985) were not observed in the infected monkeys. It is 
possible that these changes had not yet developed in the macaques at the 
time of euthanasia, which was soon after onset of coma; in contrast 
observations in humans are always on post mortem material which is at 
the end of the disease process (Desai et al., 1995; Johnson etal., 1985).
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My results are in keeping with findings in human material (Johnson et al., 
1985), where the inflammatory response was dominated by perivascular 
mononuclear cuffs with less intense infiltrates in the adjacent parenchyma. 
While T cells dominated in the perivascular infiltrates and 
macrophage/microglial cells were the largest population in the 
parenchymal infiltrates, B cells represented a minority and were restricted 
to the perivascular cuffs.
3.4.1 Role of macrophages in Japanese encephalitis
In other flaviviral infections, such as West Nile Virus (WNV), macrophages 
could serve as a reservoir, spreading the virus from the peripheral areas to 
the CNS (Samuel &Diamond, 2006). In viral encephalitis, macrophages are 
known to migrate from the perivascular space into the surrounding 
parenchyma where they become activated (Booss & Esiri, 2003). HIV- 
infected macrophages are shown to secrete MMP (Webster & Crowe, 
2006). JEV-infected macrophages that may infiltrate into the CNS due to 
chemoattraction are reported to release various inflammatory mediators in 
vitro that may contribute to tissue damage (Nazmi et al., 2011) though their 
contribution to the inflammatory process in vivo is yet to be elucidated. In 
addition to microglia, known to cause neuronal death in JE (Dasef a/.,
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2008; Ghoshal et ai, 2007), the relative contribution of peripheral 
macrophages that migrate into the CNS in JE should be studied.
3.4.2 Role of T cells in Japanese encephalitis
T cells are known to play a key role in CNS infections by destroying virus- 
infected cells, producing cytokines, increasing phagocytic activity of 
macrophages, and stimulating the local production of antibodies by B cells 
(Binder & Griffin, 2001; Chambers & Diamond 2003; Bergmann et ai, 
2006). CTLs have been reported to play a key role in mouse models of JE 
reflecting the severity of neuroinflammation (Fujii et ai, 2008; Larena etai, 
2011), but it remains to be clarified whether they are beneficial (Murali- 
Krishma etai, 1994 and 1996) or deleterious (Hase et ai, 1990; Larena et 
al., 2011). No association could be found between T-cell proliferation and 
either the antibody response or the clinical outcome (Burke et ai, 1985). In 
the present study, it was not possible to assess the role of CTLs, due to the 
lack of antibodies suitable for macaques and better understanding of their 
role in protection is needed.
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3.4.3 Role of B cells in Japanese encephalitis
It is well documented that B cells and antibodies protect against viral CNS 
infection and contribute to clearing virus from the brain (Griffin, 2003; 
Tschen et a/,,2006). Studies of post-mortem brain tissue from fatal human 
cases of JE (Johnson et a/., 1985) reported that infiltrating B cells 
remained within the perivascular spaces. However in my study it was 
clearly demonstrated that B cells were able to leave the perivascular 
compartment and invade the CNS parenchyma. Base on this finding, it is 
reasonable to suggest that both perivascular and parenchymal localization 
of B cells is important for virus clearance from CNS. The former might be 
more relevant within the perivascular spaces where B and T cells most 
often encounter each other to establish immunological synapses (Barcia et 
a/., 2008).
3.4.4 Target of JEV in CNS 
3.4.4.1 JEV in neurons
My study confirmed neurons as the main targets of JEV, as previously 
shown in fatal human cases (Desai et at., 1995; German et at., 2006; 
Johnson et al, 1985). There was diffuse distribution of JEV in neurons with 
greatest involvement of the thalamus and brainstem. The spread of the
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antigen along the axons and dendrites was conspicuous. The microglial 
reaction in the vicinity of the JEV infected neurons was not reported in 
some human studies (Desai etal., 1995). The rostral preponderance of 
JEV antigen in human studies suggest invasion of CNS from the blood 
(Johnson et al.t 1985). The presence of JEV antigen in the long dendritic 
processes and the axons, suggest a transcellular spread of virus to distant 
but functionally related neurons. The intraneuonal antigen localisation and 
the absence of neuropil staining, suggests that an extracellular spread of 
JEV to distant areas may not occur.
In contrary to some human studies (Johnson et a/., 1985) the viral antigen 
did not associate well with the inflammatory changes. Since the animals 
were euthanized relatively early in the course of infection, phagocytosis of 
infected neurons was rarely seen unlike in some human studies.
3.3.4.2 JEV in microglial cells
in addition to neurons I also examined and demonstrated viral antigen in 
microglial cells, mainly within microglial nodules surrounding infected 
neurons which suggests virus uptake by phagocytosis as microglia have a 
strong antigen presenting function (Fazakerley & Walker, 2003). JEV has
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rarely been reported previously in microglial cells of animal or post-mortem 
studies. However, it cannot be excluded that microglial cells become 
productively infected, since they do support viral replication in vitro (Chen 
et al., 2010; Thongtan et al., 2010).
S.3.4.3 JEV in perivascular macrophages
Interestingly, I was able to detect JEV antigen in perivascular macrophages 
in one animal (Figure 4.2). These cells at the interface between blood and 
brain parenchyma are resident macrophages with high phagocytic activity, 
MHC-II expression (Kida et al., 1993), CD 68+ expression, and CD163+ 
expression (Borda et al., 2008) (Figure 3.5) which suggests that they had 
phagocytosed virus that entered the brain via the blood. Perivascular 
macrophages are considered to be different from pericytes, microglia, and 
peripheral macrophages and thought to play a major role as scavengers in 
the perivascular spaces (Kida et al., 1993). Further studies are necessary 
to confirm the functional activity of the perivascular macrophages in JE 
encephalitis.
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3.3A4 JEV in other CNS cells
In my study viral antigen was not detected in other glial cells, despite the in 
vitro evidence that at least astrocytes can become infected (Chen et a/., 
2010). There was also no evidence of endothelial ceil infection unlike 
human infection (Desai et al., 1995; Johnson et at., 1985).
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Figure 3.1 Representative histopathoiogical changes in the thalamus of a rhesus 
macaque (No. 2) after intranasal inoculation with Japanese encephalitis virus (JEV). (A) 
Non-suppurative encephalitis, represented by moderate, lymphocyte-dominated 
perivascular infiltration. (B) Small vein with moderate perivascular infiltration and 
activated endothelial cells with tombstone-like morphology (arrow). (C) The presence of 
serum, indicated by staining for von Willebrand factor, in the parenchyma surrounding 
vessels with perivascular infiltrates (arrows) indicates marked vessel leakage. (D) 
Degenerating neuron (arrow) surrounded by microglial cells (satellitosis). (E) Microglial 
nodule with occasional apoptotic cells (black arrow). (F) Staining for GFAP highlights the 
presence of large numbers of activated astrocytes (astrogliosis). A, B, D, E: 
Haematoxylin-eosin stain. C, F: Indirect peroxidase method, NovaRed (C), DAB (F), 
haematoxylin counterstain. Scale bars; A, C, F = 50 pm; B, D, E = 20 pm.
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Figure 3.2 Characterization of the inflammatory response in the thalamus of rhesus 
macaques after intranasal inoculation with JEV (No. 2 (A, B, E) and No. 9 (C, D, F). (A) 
CD3+ T cells dominate the perivascular infiltrates and are present in smaller numbers in 
the adjacent parenchyma (arrows). VL: vessel lumen. (B) CD20+ B cells represent a 
minority in the perivascular infiltrates. (C) Staining for CD68 identifies moderate numbers 
of macrophage/microglial cells within and surrounding the perivascular infiltrates (arrows) 
and in the adjacent parenchyma. (D) Some positive cells in the perivascular infiltrates 
and the adjacent parenchyma (arrow) with the appearance of macrophages also express 
the myeloid/histiocyte antigen which suggested that they have recently been recruited 
from the blood. VL: vessel lumen. (E) Activated microglial cells also express major 
histocompatibility complex (MHC) class II antigen (arrowheads). MHC II is also expressed 
by vascular endothelial cells (inset, arrows), confirming their activation. (F) Microglial 
nodule with central degenerate neuron (arrow), surrounded by CD68-positive microglial 
cells. Indirect peroxidise method, DAB, Papanicolaou’s haematoxylin counterstain. Scale 
bars: A-E = 50 pm; F = 20 pm.
(Scores for each marker recorded on upper right corner)
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Figure 3,3 Demonstration of JEV target cells in the thalamus of rhesus macaques after 
intranasal inoculation with JEV [No. 7 (A, B), No. 2 (C-G)]. (A) JEV antigen is seen in the 
majority of neurons (left: arrows). Right: Infected unaltered neurons express viral antigen 
in both cell body and cell processes. (B) JEV-infected neurons that are surrounded by 
microglial cells in satellitosis appear shrunken (arrows). (C) Microglial cells in particular in 
microglial nodules can be JEV-infected (top; arrow) and are identified based on their 
CD68 expression (bottom; arrow), as demonstrated in a consecutive section. (D) Dual 
staining for JEV antigen (FITC) and GEAR (Texas red) indicates that JEV does not infect 
astrocytes. (E) While endothelial cells (arrowheads) were not found to be JEV infected, 
perivascular macrophages in one animal were found to express JEV antigen (Texas Red); 
these cells were also undergoing apoptosis, since they were TUNEL-positive (FITC) 
(arrows). VL: vessel lumen. (F) Dual staining for JEV antigen (Vector Blue) and TUNEL 
(DAB) shows both the degenerating neurons and surrounding microglial cells in 
satellitosis undergo apoptosis (arrows). JEV-infected, apoptotic microglial cells 
(arrowhead) are also observed. (G) Occasional TUNEL-positive, apoptotic lymphocytes 
(arrows) are present in the perivascular infiltrates. Rare endothelial cells (arrow) were 
found to be undergoing apoptosis (inset). V: vessel. Indirect peroxidase method (A-E, G), 
Vectastain® Elite ABC-Alkaline Phosphatase Kit (F). DAB (A-G), BC/P/NBT blue (F), 
Papanicolaou’s haematoxylin counterstain. Scale bars: A (left) = 100 pm; A (right), C = 25 
pm; B, E = 20 pm; D, F, G = 50 pm.
(Scores for each marker recorded on upper left corner)
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Table 3.1 Semi-quantitative analysis of Japanese encephalitis virus antigen and 
inflammatory cells in the brain of monkeys following Japanese encephalitis virus 
infection
Monkey
No.
Tissue JEV
antigen
CDS
PHENOTYPING
CD20 CD68 MAC387
1 B 2+ 2+ 2+ 3+ 3+
T 3+ 2+ 3+ 2+ 3+
2 B 2+ 2+ 1 + 3+ 3+
T 3+ 3+ 1 + 3+ 3+
3 B 1 + 3+ + 3+ 2+
T 1 + 2+ + 3+ 2+
4 B 1 + 3+ 1 + 3+ 3+
T - 2+ 1 + 3+ 1 +
5 B 2+ 2+ 1 + 3+ 2+
T 2+ 3+ 1 + 3+ 2+
6 B 2+ 2+ 1 + 3+ 2+
T 2+ 2+ 1 + 3+ 2+
7 B - 2+ 1 + 3+ 3+
T 2+ 3+ 2+ 3+ 3+
8 B 2+ 2+ 1+ 3+ 3+
T 1 + 2+ 1+ 3+ 3+
9 B 1 + 3+ 1+ 2+ 2+
T - 2+ 1+ 3+ 2+
10 B 3+ 2+ 1+ 3+ 3+
T 3+ 3+ 1+ 3+ 3+
11 B 2+ 2+ 1+ 3+ 2+
T 2+ 2+ i+ 3+ 2+
12 B 1 + 2+ 1+ 3+ 1 +
T 3+ 2+ 1+ 3+ 1 +
Mean 2+ 2+ 1+ 3+ 2+
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Extent and intensity of the immunoreactivity was scored on paraffin sections of brainstem 
and thalamus and recorded as: 0 = no difference from the negative control with regard to 
intensity, distribution and number of positive cells, or no positive reaction, 1+ = occasional 
individual positive cells, 2+ = a few nests of positive cells, 3+ = frequent positive cells 
JEV Ag = JEV antigen 
CDS = Pan T cell 
CD20 = B cell
CD68 = macrophage/microglial cells
MAC 387 = anti human myeloid/histiocyte antigen {reactive macrophage/microglial ceils)
B = Brain stem 
T = Thalamus
75
Histopathology, Phenotyping and JEV Target Cells
Perivascular
Macrophage
Figure 3.4 Perivascular macrophages
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CHAPTER 4
APOPTOSIS
4.1 Introduction
This chapter aims to examine the mechanisms of neuronal damage and 
the apoptosis pathways in JE infection.
After an acute CNS injury early necrotic cell death is known to take place 
and is followed later by a delayed apoptotic death. Elucidating whether 
apoptosis contributes to neuronal cell death was one of the main aims of 
this thesis, therefore its study has provided for the majority of results and 
discussion.
4.1.1 Apoptotic cell death
Although it is well established that apoptotic mechanisms pay a central role 
in neuronal death following CNS damage, little is known about the 
apoptotic pathways in Japanese encephalitis. Apoptosis or programmed 
cell death is a characteristic process of cell suicide that has distinctive 
morphological features, including cell shrinkage, membrane blebbing, 
chromatin condensation and nuclear fragmentation (Kerr et al., 1972)
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(Figure 4.1). The fragmented nucleus is packaged into vesicles, called 
apoptotic bodies, which may be phagocytosed.
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Apoptosis
4.1.2 Caspases
TUNEL assay based on DNA fragmentation is subject to problems of 
sensitivity, but evidence of caspase activation is considered a 
complementary method for demonstrating the presence of apoptotic 
features.
Caspases are proteases, which become activated in most forms of cell 
death. In the cell, caspases are localized in the nucleus, cytoplasm, 
endoplasmic reticulum, and mitochondria] intermembrane space, and they 
can be translocated to the plasma membrane. Caspases are categorized 
into initiator caspases (caspasesS, 9, and 10) and effector or executioner 
caspases (caspasesl, 2, 3, 4, 6, 7, 12, and 13) (Salvesen & Dixit, 1997). 
Caspases exist as latent precursors, which, when activated, initiate the 
death program by sequential activation. They are present in cells as 
zymogens and need to undergo proteolytic cleavage in order to achieve 
their enzymatic activity.
4.1.3 Caspase cascades: two pathways
Two main pathways of apoptosis signalling have been well documented in 
the mammalian cells; the "extrinsic” or death receptor pathway (Hirata et
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a/., 1998), and the “intrinsic” or mitochondrial pathway (Li et al., 1997) 
(Figure 4.2).
4.1.3.1 Intrinsic Pathway
Mitochondria play an important role in the execution process of the 
apoptotic program by acting as a reservoir for a multitude of apoptogenic 
proteins. After release from the mitochondria, cytochrome c associates with 
the apoptosis protease activating factor - 1 (Apaf-1) triggering the 
subsequent recruitment and auto processing of inactive procaspase-9 to 
form the apoptosome complex, hence initiating downstream caspase 
activation (Costantini et al., 2002). Activation of caspase-9 precedes the 
maturation and activation of effector caspase-3 (Figure 4.2).
4.1.3.2 Extrinsic Pathway
Several extrinsic ligands can activate “death receptors” of the tumour 
necrosis factor receptor (TNFR) family, including FAS/CD95 or TNFR-1. 
The FAS ligand (FASL/CD95L) is a member of the TNF family of cytokines 
and its activation of FAS leads to the recruitment of FAS-associated death 
domain (FADD) and promotes caspase 8 activation (Rytomaa etal., 1999). 
This then leads to activation of effector caspases (Figure 4.2).
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4.1.4 Main executor: Caspase 3
Caspase-3 is a principal downstream effector of the cascade in charge of 
the execution of apoptotic cell death in both intrinsic and extrinsic 
signalling pathways (Stennicke & Salvesen, 2000). It appears to be the 
most abundant of the caspases in the brain and the convergence of all 
caspase-mediated pathways related to apoptosis. Caspase 3 is activated 
in several neurodegenerative disorders (Namura eta!., 1998, Hartmann et 
al, 2000, Su eta!., 2000). Caspase-3 dependent neuronal damage is also 
reported in WNV encephalitis (Samuel et al., 2007).
4.1.5 Apoptotic Proteins
The apoptosis-regulating proteins play an important role in the regulation 
of apoptosis (Cory et al., 2003). Apoptotic factors activated after an insult 
are usually accompanied by over expression of molecules aimed to inhibit 
them: the anti- apoptotic proteins. The balance between pro-apoptotic and 
anti- apoptotic groups will finally determine if the cell will die or survive. The 
anti- apoptotic group includes Bcl-2, Bcl-xs, Bcl-w and the pro-apoptotic 
group includes Bax, Bak, Bok, and Bcl-xl. The apoptosis-inducing factor 
(AIF), a mitochondrial intermembrane flavoprotein with pro-apoptotic 
effects, involved in a caspase-independent pathway (Joza et al., 2001),
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was not studied for this thesis (Figure 4.2).
4.2 Materials and Methods
Following routine paraffin wax embedding, 3-5 pm sections were prepared 
and stained with apoptosis markers as specified in Table 2.2. HIER was a 
requirement for all markers. Optimal conditions for antigen retrieval and 
antibody dilutions (Table 2.2) were independently determined by 
comparative titration experiments. Apoptotic cells were identified by the 
terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate 
nick end in situ labelling (TUNEL) method using the Apoptag In Situ 
Apoptosis Detection kit (Chemicon Inc., Millipore, Billerica, USA) to 
demonstrate the characteristic DNA changes (Gelbard et a!., 1995; Kerr et 
al.t 1972). Double immunostaining of apoptosis markers and JEV was 
performed as described in Chapter 2 (Table 2.3). Apoptosis related 
proteins TNFR-1, FAS and FASL did not work well with macaque tissue 
sections.
4.3 Results
4.3.1 TUNEL
In this study I characterized the type of cells undergoing apoptosis by
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TUN EL technique, a marker of DNA damage, which identified apoptotic 
JEV-infected neurons in microglial nodules and satellitosis as well as 
apoptotic microglial cells disseminated in the parenchyma, in satellitosis 
and in microglial nodules (Figure 3.3F). Occasional lymphocytes in the 
perivascular infiltrates were also apoptotic (Figure 3.3G) and the JEV- 
infected perivascular macrophages observed in animal 2 did also undergo 
apoptosis (Figure 3.3E). Very rarely, an apoptotic endothelial cell was seen 
(Figure 3.3G, inset). Some apoptotic neurons were JEV infected. The 
extent of apoptotic neurons did not correlate with the presence of JEV.
4.3.2 Caspase activation in JE
Staining for key apoptosis molecules, such as caspases-8, -9 (both initiator 
caspases) and cleaved caspase-3 (an executor caspase) was undertaken 
to identify cells undergoing apoptosis that did not yet show the 
representative morphological features. Among unaltered appearing 
neurons, cleaved caspase-3 expression was seen in small numbers (mean 
score = 1+) compared to caspase-8 (mean score = 3+). Both caspases 
were also expressed by some leukocytes (macrophages and T cells) in the 
perivascular infiltrates (Figure 4.3A, B). Caspase-3 staining was also seen 
in nucleus and axonal prolongations. In contrast, caspase-9 activation, was
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only detected in astrocytes and microglial cells (Fig. 4.3C). Double staining 
for JEV and the various caspase markers confirmed that some JEV- 
infected neurons were undergoing apoptosis (Figure 4.4A.B).
4.3.3 Apoptotic Proteins
In order to gain some understanding of the regulation of apoptotic 
processes in the relevant cells, the expression of representative pro- and 
anti-apoptotic proteins was assessed. While numerous microglial cells and 
occasional neurons stained positive for the pro-apoptotic protein Bax 
(mean score = 3+) (Figure 4.3D), the anti-apoptotic protein Bcl-2 was 
mainly expressed by lymphocytes in the perivascular infiltrates (mean 
score = 1+) (Figure 4.3E). Dual staining showed JEV antigen in some Bax­
positive neurons (Figure 4.5A) and occasional Bax-positive microglial cells 
(Figure 4.5B).
In uninfected control brains TUNEL positive cells were not identified. 
Caspase and Bcl-2 staining was negligible; weak and infrequent Bax 
expression was seen in neurons (Figure Appendix1.2). Semi-quantitative 
analysis of apoptosis markers was summarized in Table 4.1.
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4.4 Discussion
4.4.1 Neuronal apoptosis - intrinsic vs. extrinsic pathways
Viral infection and inflammatory response were associated with cytopathic 
changes, and, although not excessive, neuronal death via apoptosis was 
clearly observed. The latter was confirmed not only by the TUNEL assay 
which has been used in the past to demonstrate apoptosis but can provide 
controversial results in the presence of necrosis and autolytic changes 
(Grasl-Krauppef a/., 1995), but also by staining for cleaved caspase-3 and 
some apoptotic proteins (Figure 5.3). Apoptotic neurons were often 
surrounded by microglial cells (satellitosis and formation of microglial 
nodules) which indicated their impending phagocytosis (Fuller & Eldik, 
2008). Some apoptotic neurons were JEV infected. In addition, some 
morphologically unaltered, infected neurons were shown to express the 
pro-apoptotic protein Bax, the initiator caspase-8 or the active effector 
caspase-3 (Yang et al, 1998), which indicates that these cells were also 
doomed to undergo apoptosis. These results confirm the in vivo relevance 
of previous in w'frostudies which demonstrated that JEV replication can 
lead to neuronal apoptotic death (Liao et al., 1997; Raung et al., 2001; 
Tsao et al., 2008; Yang et al, 2009) and support findings in the mouse 
model that JEV replication contributes to Bax activation (Mishra & Basu,
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2008). Taken together, all these findings provide evidence of a direct, 
although possibly not rapid cytopathic effect of JEV on neurons. The 
demonstration of caspase-8 in affected neurons also indicates that 
neuronal apoptosis is initiated by the FAS-mediated or extrinsic pathway 
(Hirata et al., 1998), a mechanism that is central to the process of immune- 
mediated viral clearance (Clarke & Tyler, 2009) and seen in a number of 
CNS viral infections including WNV (Ramanathan et al., 2006).
One of the main candidates of caspase-independent mediators of cell 
death isAIF (Joza etal., 2001), which is released from the mitochondria 
and reaches the nucleus where it can directly induce DNA fragmentation. 
The results from my study emphasize the involvement of the extrinsic 
pathway over the intrinsic pathway in neuronal death in JE. However it 
should be mentioned that it might also coexist with other caspases or 
caspase-independent apoptotic pathways or with necrotic cell death.
Bystander neuronal cell death
Importantly, apoptotic cell death or pre-apoptotic caspase-3 and -8 
expressionswere also seen in a proportion of JEV antigen-negative 
neurons, (Figure 5.4) which suggests some degree of bystander neuronal
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death.
4.4.2 Glial cell apoptosis
Both in vivo and in vitro studies showed that glial cells are also sensitive to 
apoptotic stimuli. Neurons are described as the most vulnerable cell type to 
apoptotic damage, followed by oligodendrocytes, astrocytes, endothelial 
cells, and microglia (Li ef a/., 1995; Petito et al., 1998). In our study a 
proportion of microglial cells, often in close proximity to infected neurons 
but generally not JEV-infected, were shown to undergo apoptosis. Further, 
morphologically unaltered microglial cells expressed caspase-9 which 
suggests that microglial apoptosis is initiated by the mitochondria or the 
intrinsic pathway. While a recent in vitro study showed that JEV infection 
can lead to apoptosis of microglial cells (Thongtan et al., 2010), our results 
indicate that in vivo this direct mechanism is probably less relevant and 
that pro-inflammatory factors are more relevant, as in other CNS 
conditions, such as experimental autoimmune encephalomyelitis (EAE) 
where microglia! apoptosis is considered an important homeostatic 
mechanism to control microglial activation and proliferation (White et al., 
1998).
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4.4.3 Inflammatory cell apoptosis
Apoptotic cell death was also observed in a proportion of infiltrating 
inflammatory cells (macrophages and T cells). Considering that these cells 
were not JEV-infected, this most likely represents a normal mechanism to 
eliminate activated leukocytes and thereby limit the inflammatory response 
in the CNS (Baeur etal., 1998). On the other hand, perivascular leukocytes 
(predominantly T cells) were found to express the anti-apoptotic protein 
Bcl-2. This supports a murine in vivo study that provides evidence of a 
critical role of Bcl-2 in the survival of virus-specific CTLs (Grayson et al., 
2000).
In summary, I have shown in this study that neuronal death is contributed 
by both the cytopathic and bystander effect and that neurons undergo 
apoptosis mainly by the extrinsic pathway and microglial cells by intrinsic 
pathway. The role of apoptotic proteins like FAS, FAS-L, TNFR as well as 
caspase-independent pathways should be explored to guide the best 
strategies to limit neuronal damage in JE.
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Table 4.1 Semi-quantitative analysis of Japanese encephalitis antigen and 
apoptosis markers in the brain of monkeys following Japanese encephalitis virus 
infection
Monkey
No.
Tissue JEV
antige
n
APOPTOSIS
TUNEL Cas-3 Cas-8 Cas-9 Bax Bcl2
1 B 2+ 2+ 2+ 2+ 2+ 3+ 2+
T 3+ 2+ 1 + 3+ 1 + 3+ 2+
2 B 2+ 2+ 1 + 3+ 2+ 3+ 2+
T 3+ 2+ 1 + 1 + 1 + 3+ 2+
3 B 1 + 2+ 1 + 1 + + 1 + -
T 1 + 1+ + 2+ + ± -
4 B 1 + 1+ - 2+ - 2+ -
T - 2+ 1 + 1 + 1 + ± -
5 B 2+ 1 + 1 + 2+ 1 + 3+ 1 +
T 2+ 2+ - 2+ 1 + 1 + -
6 B 2+ 2+ 1 + 2+ 1 + 3+ -
T 2+ 2+ 1 + 1 + 1 + 1 + -
7 B - 2+ 1 + 1 + + 2+ 1 +
T 2+ 2+ ± 1 + + - 1 +
8 B 2+ 1 + 1 + 2+ 2+ 3+ 1 +
T 1 + 2+ 1 + 2+ 2+ 2+ 1 +
9 B 1 + 3+ 1 + 2+ 2+ 3+ 1 +
T - 1 + 1 + - 1 + + -
10 B 3+ 2+ 1 + 3+ 3+ 3+ 2+
T 3+ 3+ - 1 + 2+ 3+ -
11 B 2+ 2+ 1 + 2+ 2+ 3+ 2+
T 2+ 2+ 1 + 2+ ± 2+ 3+
12 B 1 + 2+ 2+ 2+ - 2+ -
T 3+ 2+ 1+ 2+ + 2+ 2+
Mean 2+ 2+ 1+ 2+ 1 + 2+ 1 +
94
Apoptosis
Immunohistochemistry of cell markers tested on paraffin sections of brainstem and 
thalamus and the level of expression recorded as:
0 = no expression observed above the negative control
1+ = occasional isolated positive cells
2+ = a few nests of positive cells
3+ = frequent positive cells in most brain areas
Cas-3 = Caspase - 3
Cas-8 = Caspase - 8
Cas-9 = Caspase - 9
Bax = Pro-apoptosis protein
Bcl2 = Anti-apoptosis protein
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Pro-inflammatory Mediators, Glial and Endothelial Cell Response in JE
CHAPTER 5
PRO-INFLAMMATORY MEDIATORS, GLIAL AND 
ENDOTHELIAL CELL RESPONSE IN JE
5.1 Introduction
This chapter aims to examine the contribution of pro-inflammatory 
mediators and the involvement of non- neuronal cells in the pathogenesis 
of JEV infection.
Having characterized the inflammatory response and the patterns of cell 
death in JE, I aimed to identify relevant mediators of these processes 
within the CNS as well as the possible roles of glia! and endothelial cells by 
immunohistology.
5.1.1 Nitric Oxide (NO) production in JE
Because of its biochemically promiscuous nature, NO has been suggested 
to contribute to a myriad of physiological and pathological processes. NO 
can act as both a ’mediator and murderer’ (Anggard, 1994), acting to 
regulate a physiological process in one context but disrupt it in another.
Like many inflammatory mediators, it is clear that NO is a double-edged
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sword, mediating host defence in certain contexts but damaging the host in 
others. Relatively little is known about the role of NO in mediating 
inflammation in the pathophysiology of JE encephalitis. It is shown to 
irreversibly damage lipids and proteins in cells (ladecola & Zhang, 1996), 
negatively regulate mammalian neurogenesis (Packer et al., 2003), and 
enhance glutamate exictotoxicity (Hewett et al., 1996). NO is known to be 
a potential mediator of neuronal injury and to mediate BBS damage both in 
vivo (Parathath et al., 2006) as well as in vitro studies (Wong et al., 2004).
It is also implicated as a contributor to the host’s innate defense against 
viral infection in those affecting the CNS. To assess local NO production in 
the infected CNS sections, I investigated the expression of both indicators 
of oxidative stress - iNOS and nitrotyrosine (NT) (MacMicking et al., 1997; 
Jinno-Oue et al., 2003), as not all human antibodies work well for monkey 
tissues.
5.1.2 Matrix metalloproteinases (MMP) in JE
MMPs are proteins known to degrade components of extracellular matrix 
(ECM) (Rosenberg et al., 2002) and reported to be secreted by astrocytes, 
microglia and vascular endothelial cells (Lukes et al., 1999). They are 
recognized as important immunoregulatory modulators during inflammatory 
response (Webster and Crowe, 2006). In spite of the accumulating
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evidence of MMPs in the pathogenesis of several CNS diseases (Kieseier 
et a/., 1999) very little is known about the MMP expression in vivo and its 
significance in JE. I stained for MM P-2 and -9, which are known to cause 
BBB disruption by degrading collagen IV, its main component (Rosenberg, 
1998). To the best of my knowledge this study represents the first study of 
MMP expression in vivo in JE infection and the significance of these 
findings is discussed.
5.1.3 Cytokines in JE
Cytokines play a major role in the orchestration of the local immune 
response by regulating adhesion, chemotaxis, activation and differentiation 
of cells. Several studies have shown that cytokines are produced by cells 
intrinsic to the CNS as part of the innate immune response to viral infection 
before the infiltration of inflammatory cells from the periphery (Griffin,
1997). In CNS infection the cytokines produced locally are likely to 
influence both the manifestations of disease and the outcome of infection 
(Owens ef a/., 1994). IFN-a, a potent antiviral cytokine and microglial 
activator (Paul et al., 2007.); and TNF-a which has been shown to directly 
activate microglia (Basu et al., 2002) and induce neuronal apoptosis 
(Venters et al., 1999) were implicated to play important roles in CNS 
infections. IFN-a does not seem to be strongly upregulated in acute
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encephalitis but has been reported in the plasma and CSF in severe 
infection with a fatal outcome (Burke and Morrill, 1987). TNF-a is known as 
a key trigger of the inflammatory response within the CNS and reported to 
exert direct anti-viral effects In vitro (Ramsey et al., 1993). It is also shown 
to cause MMP-9 increase and subsequent BBB permeability in a murine 
model (Rosenberg, 1995). Although a number of pro-inflammatory 
cytokines were shown to be expressed in mouse in vivo studies (Gupta et 
al., 2010; Yang et al., 2011), the role of other cytokines were not 
investigated in this study due to restriction of antibodies available for 
monkey paraffin sections.
5.1.4 Involvement of non-neuronal cells
This chapter also summarizes the possible roles of glial and endothelial 
ceils in JE that might be contributing to neuronal damage. The loss of BBB 
integrity in JE is discussed in detail in Chapter 6.
5.1.4.1 Microglial cells
Microglia, the resident immune cells of the CNS and widely distributed 
within brain parenchyma constitutes up to 12% of CNS cells, and has been 
implicated as critical cells in JE encephalitis in a mouse model (Ghoshal et 
al., 2007). They are known as the predominant source of pro-inflammatory
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mediators in CNS infections; the soluble effectors released from activated 
microglia like IL-1f3, IL-3, lL-6, TNF-a, vascular endothelial growth factor 
(VEGF), lymphotoxin, macrophage inflammatory protein 1a (MIP-la), 
IVIMPs, NO and reactive oxygen species (ROS) (Banati & Kreutzberg,
1993; Colton & Gilbert, 1987; Gehrmann et al., 1995; Kielian, 2004; Smith 
etal., 2012) are instrumental in inducing neuronal death (Chen et al.,
2010; Rock etal., 2004). Activation of microglia induces changes in cellular 
morphology (from a ramified resting state to an amoeboid activated state) 
and in the expression of cell surface receptors that results in an 
appearance very similar to a tissue macrophage (Davis et al., 1994).
5.1.4.2 Astrocytes
Astrocytes are the predominant glial cell population in the CNS and 
maintain homeostasis in the CNS to support the survival and information 
processing functions of neurons. They are also known to respond promptly 
to CNS infection and help regulate neuroinflammation (Kuhlow et al.,
2003). GFAP is an intermediate filament protein which is known to be 
expressed in astrocytes, although its precise contributions to astroglial 
physiology and function are still not clear. The upregulation of GFAP is the 
main landmark of reactive astrogliosis in neurodegenerative conditions and 
acute neuronal damage (Eng & Ghirnikar, 1994). Early astroglial activation
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can be seen within hours after injury when the astrocytes generally show 
an increase of GFAP immunoreactivity associated with ceil hypertrophy 
and sometimes proliferation. Astrocytes are shown to be involved in the 
repair of ECM by secreting ECM proteins like MMPs (Lukes et al., 1999). 
Astrocytes, together with microglial cells, endothelium and infiltrating 
leukocytes are the major players of the inflammatory response after CNS 
damage and they have shown to produce inflammatory cytokines including 
TNF-a, and the inflammatory enzyme iNOS. Whether astrocytes are 
protective or pathogenic is controversial (Singh et al., 2011) and the exact 
role of astrocytes in the pathogenesis of JE remains unknown. Previously, 
in studies using H-E staining, an astrocytic reaction was not thought to be 
a prominent feature in JE although some astrocytes are infected by JEV 
(Desai et al., 1995).
5.1.4.3 Endothelial cells
The cerebral endothelium is involved both in regulating the influx of 
immune cells into the brain and in modifying immunological reactions 
within the CNS. A number of human pathogens may cause encephalitis or 
meningitis when this important protective barrier is impaired. The 
endothelial cells lining cerebral microvessels and forming BBB are 
characterized by limited vesicular transport, limited pinocytotic vesicles,
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selective active transport mechanisms and the presence of continuous 
tight junctions (Joo, 1985; Turner ef a/., 1987; Goldstein & Lords Betz, 
1983).
5.2 Materials and Methods
Following routine paraffin wax embedding, 3-5 pm sections were prepared 
and stained with pro-inflammatory markers as specified in Table 2.2. HIER 
was a requirement for all markers. Optimal conditions for antigen retrieval 
and antibody dilutions (Table 2.2) were independently determined by 
comparative titration experiments. The anti-human IL-1(S and IL-6 markers 
as well as CD31 endothelial cell marker did not work well with macaque 
tissue sections.
5.3 Results
5.3.1 Pro-Inflammatory mediators
Both iNOS and NT were expressed by microglial cells and astrocytes. 
iNOS expression was also seen in some macrophage/microglial cells in the 
perivascular infiltrates and the adjacent parenchyma (Figure 5.1 A, B)
(Table 5.1) where staining for NT was only very weak. MMP-2 was 
expressed in cells with the morphology of reactive astrocytes (Figure 5.1 C)
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(Table 5.1) and, to a lesser extent, in microglial cells and in infiltrating 
macrophages, whereas MIVIP-9, known to be constitutively expressed in 
human neurons (Rao et aL, 1996), was intensely expressed by neurons 
and relatively weakly by microglial cells (Figure 5.1D) (Table 5.1). TNF-a 
expression was seen in macrophage/microglial cells and astrocytes, as 
dual staining with CD68 and sequential staining with GFAP confirmed 
(Figure 5.1 E). It was also occasionally seen in endothelial cells (Figure 
5.1 E inset). IFN-a expression, however, was seen both in uninfected and 
infected neurons, as confirmed by dual staining with JEV antigen (Figure 
5.2), and in astrocytes and microglial cells (Figure 5.1 F). In control brains, 
only minimal expression of inflammatory mediators was seen, represented 
by staining in occasional vascular endothelial cells (iNOS, TNF-a), neurons 
(MMP-9, iNOS) and vascular smooth muscle cells (TNF-a) (Figure 
Appendix1.3).
5.3.2. Non-neuronal cells
Chapter 3 confirmed the involvement of microglia! cells in JE in the form of 
microglial nodules (Figure 3.1 E), diffuse microgliosis, and activation 
(Figure 3.2C,E). In Chapter 5, l have identified that they expressed iNOS 
(Figure 5.1 A), NT (Figure 5.1 B), TNF-a (Figure 5.1E), and IFN- a (Figure 
5.3A) and MMP-9 (Figure 5.3B).
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1 also described the involvement of astrocytes in the form of reactive 
astrogliosis (Figure 3.1F). In Chapters, I have identified that they 
expressed iNOS (Figure 5.1A), NT (Figure 5.1B), MMP-2 (Figure 5.1C), 
TNF-a (Figure 5.1E), and IFN-a (Figure 5.1F and 5.2).
In addition I also provided evidence that endothelial cells might be 
involved in terms of their activation in Figure 3.1 B, 3.2E. They were also 
identified to secrete TNF-a (Figure 5.1E, inset). Endothelial infection was 
not observed in any of the animals. Semi-quantitative analysis of pro- 
inflammatory markers was summarized in Table 5.2.
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5.4 Discussion
The upregulation of iNOS and cytokines as well as microglial activation 
have been reported in earlier studies with a mouse model. This chapter 
confirms the previous findings in a macaque model and highlights the 
possible contribution of astrocytes in neuronal death which has never been 
fully explored in vivo in any flavivirus encephalitis.
5.4.1 Role of Cytokines in JE
Most of the cytokine antibodies as well as the mRNA expression work well 
only in fresh frozen tissues. The expression and possible roles of TNF-a 
and IFN-a in the inflammatory network were studied in this thesis as it 
worked reliably in paraffin embedded tissues.
The occurrence of apoptosis in apparently uninfected neurons suggests 
that indirect mechanisms (bystander cell death) contribute to neuronal 
damage in JE (Andrews et al., 1999; Schoneboom et a/., 2000), and 
indeed recent in vitro and in vivo murine studies demonstrated that 
microglial cells can induce neuronal apoptosis via the release of pro- 
inflammatory mediators (Dasef a/, 2008; Ghoshal et al., 2007). Also, TNF- 
a, via its receptor on neurons, has been shown to induce caspase-8
107
Pro-inflammatory Mediators, Glial and Endothelial Cell Response in JE
activation in mouse neurons (Badiola et al., 2009). I observed TNF-a 
upregulation in infected macaques and was able to identify astrocytes, 
microglial cells, endothelial cells and infiltrating macrophages as the 
source of the cytokine. It is likely that these cells were also responsible for 
the TNF-a upregulation observed in JEV-infected mice by bead array and 
RT-PCR (Biswas et al., 2010; Fujii et al., 2008; Ghoshal et al., 2007; 
Mishra & Basu, 2008; Saxena et al., 2008). TNF-a related neuronal death 
is established in a recent in vitro study with WNV (Kumar et al., 2010).
IFN was shown to play a part in the innate response to CNS viral infection, 
the rapid local production of type 1 (IFN-a and IFN-(3) could decrease virus 
replication and prevent neuronal death in a WNV mouse model (Samuel & 
Diamond, 2005). Type II interferon (IFN-y) is believed to be a key cytokine 
in the activation of microglial cells and serves critical functions in both 
innate and adaptive immunity (Griffin, 2003). The role of IFN-y in the 
inflammatory cascade in JE is not determined in this thesis. However, 
ffaviviruses appear to be capable of attenuating some IFN-dependent 
antiviral effector mechanisms (Chamber & Diamond, 2003). Further 
definition of the underlying mechanisms will allow us to understand the 
processes involved in disease progression and to assess the potential of
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anti-apoptotic treatment strategies (Ciarke and Tyler, 2009).
Cytokine profiling in paraffin sections with quantitative real time - 
PCR (qRT-PCR)
I attempted to profile the cytokine expression from paraffin sections of JE 
infected rhesus monkeys although these studies are strongly dependent 
on sample preparation. It was reported that fixation of tissue samples in 
formaldehyde leads to extensive cross linking of all tissue components. As 
a consequence of this cross-linking, the nucleic acids isolated from these 
specimens are highly fragmented. Studies also showed that extent of 
fragmentation of extracted RNA significantly increases with archive storage 
time which in my case is more than a decade. I attempted to study the 
mRNA expression of gene targets IL-1(B, IL-6 and IL-18. While all efforts 
are made to achieve optimal results by using advanced biomaterials 
including sophisticated PCR instrumentation, RNA isolation kits, and highly 
purified Taq polymerase, the assay was unsuccessful. Majority of the 
tissue used for qRT-PCR were those fixed for undetermined period (more 
than 1-2 weeks) in formaldehyde that might have caused more 
fragmentation of RNA. It might also due to the primers, some of which are 
larger amplicon sizes although I have chosen primers that produce PCR
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products as short as possible.
5.4.2 Role of nitric oxide in JE
iNOS and NT expression in my study indicate NO production, which is in 
accordance with results from a mouse study (Saxena et a/., 2001). There, 
a gradual increase in iNOS activity was observed after intracranial JEV 
infection, and was considered a consequence of release of cytokines, such 
as TNF-a or IL-8 which might be beneficial through the inhibition of viral 
replication and release (Saxena et al., 2001). NO has also been discussed 
as a potential mediator of pathogenesis in TBEV infection (Kriel & Eibl, 
1996), but its role in WNV has not been established (Samuel & Diamond, 
2006). The contribution of NO to the inflammatory process is a subject of 
some controversies and its role in the inflammatory pathway of JE has yet 
to be proven.
5.4.3 Role of matrix metalloproteinases in JE
I am particularly interested in studying MMP in CNS in JE as unlike NO 
and cytokines their role in the regulation of neuronal cell death in JE has 
never been explored. Increased production of MMPs has been 
demonstrated by WNV in a mouse model (Roe ef a/., 2012). MMP levels
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have been shown to correlate with the severity of some CNS infections 
(Leppert at al., 2000). MMP-9 is known to be constitutively expressed in 
human neurons (Rao et al., 1996). However, in my study it was intensely 
upregulated in neurons of the JEV-infected macaques and weakly 
expressed by microglial cells, while astrocytes and macrophage/microglia 
were sources of MMP-2. MMP release is stimulated by pro-inflammatory 
cytokines including TNF-a (Gottschall and Deb, 1996). In JE, MMPs might 
play a detrimental role and not only be responsible for BBB disruption 
through collagen IV degradation (Gearing etal., 1994), but also contribute 
to neuronal destruction via stimulation of TNF-a release. MMP over 
expression in my study supports its likely role in mediating BBB disruption, 
influx of leucocytes into the CNS and secondary neuronal damage. My 
results suggest that adjunctive therapy with selective MMP inhibitors may 
prove to be of benefit to prevent neurodegeneration in JE.
5.4.4 Non-neuronal cells 
5.4.4.1 Microglial response
Alongside the inflammatory infiltration and the cytopathic effects, I found 
distinct evidence of activation of a range of cells, namely microglial cells, 
astrocytes and vascular endothelial cells. Microglial activation was
111
Pro-inflammatory Mediators, Glial and Endothelial Cell Response in JE
confirmed by the demonstration of MHC II antigen, iNOS, NT, TNF-a and 
MMP expression by microglial cells (Rock et a/., 2004) and has been 
reported previously in JEV-infected mice (Ghoshal et al., 2007). To shed 
light on the potential mechanism of microglial activation, I assessed the 
expression of IFN-a (type IIFN); this potent antiviral cytokine (Samual, 
2001) is an activator of microglia in response to CNS viral infection (Paul et 
al., 2007), and is elevated in the CSF of patients with JE, where it is 
associated with a poor outcome (Winter et al., 2004). I demonstrated IFN-a 
expression in neurons which suggests that they might be responsible for 
microglial activation early after infection; expression by microglia and 
astrocytes suggests they might be responsible for sustained microglial 
activation in JE.
5.4.4.2 Astrocyte response
Astrocytes are the major cellular component of the brain that is capable of 
intense proliferation and metabolic activity during many inflammatory brain 
diseases. As described in earlier reports (Chen etal., 2011; German et al., 
2006), reactive astrogliosis was observed in this study as in WNV (Lim et 
al., 2011). Astrogliosis is considered as a non-specific response to 
degenerative changes including virus-induced damage in the CNS (Booss
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& Esiri, 2003). However, a recent study provided evidence that this 
activation might be an effect of TNF-a release from microglial cells (Chen 
eta/., 2010). Nevertheless, the demonstration of TNF-a, IFN-a, iNOS, NT 
and MM P-2 expression by astrocytes in my study provides the first in vivo 
evidence that astrocytes may play an important role in the pathogenesis of 
JE. The same is true for microglial cells and macrophages in the 
inflammatory infiltrates, since through release of the inflammatory 
mediators, all these cells might actively contribute to the damage of other 
cells in the brain and in particular induce bystander apoptotic death of 
neurons (Das etal., 2008; Ghoshal etal.} 2007; Maximova et al., 2008). 
While a number of studies have documented the importance of microglia in 
JE encephalitis, little is known regarding the role of astrocytes in 
neuroinfiammation and neuronal death. More research is required to 
determine the precise role of astrogliosis and its implication on the 
neuropathogenesis of JE.
5.4.4.3 Activation of vascular endothelial cells
Without a specific marker, the role of endothelial cells cannot be confirmed 
in my study. However the expression of MHC II antigen and TNF-a in 
endothelial cells suggests that they are activated and implies they might
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have a role in inflammatory cell recruitment and potential contribution to 
immune reactions, glial cell activation and neuronal apoptosis. Endothelial 
cells might also be a source of the increase in serum TNF-a seen in JE 
patients (Winter et aL, 2004). Reports on WNV suggest that endothelial 
cells are activated (Verna et a/., 2009) and virus may cause damage to the 
vascular endothelial cells, leading to disruption of BBS (Diamond & Klein, 
2004). However the precise role of endothelial cells in flavivirus 
encephalitis has not been defined.
In summary my study indicated that pro-inflammatory markers produced by 
glial and endothelial cells are likely to be important in the amplification of 
inflammatory and immune reactions and may trigger the inflammatory 
response, neuronal apoptosis and progression of disease.
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Figure 5.1 Demonstration of pro-inflammatory markers in the thalamus of rhesus 
macaques after intranasal inoculation with JEV (No. 2 (A, B, D-F), No. 11 (C)). (A) 
Microglial ceils (small arrows), leukocytes in the perivascular infiltrates (arrowheads), 
perivascular macrophages (large arrow) and astrocytes (inset) express iNOS. (B) 
Nitrotyrosine expression is observed in microglial cells (arrowheads) and astrocytes 
(arrows). VL: vessel lumen. (C) MMP-2 expression is diffusely seen in reactive astrocytes. 
(D) MMP-9 is mainly expressed by neurons. (E) TNF-a (left: brown signal) is expressed by 
microglial cells (left: arrows; right: arrowheads) that are identified based on their CD68 
expression (left: blue signal), endothelial cells (left: arrow, inset), and astrocytes (right: 
arrows). (F) IFN-a expression is seen in astrocytes (left; arrow) and neurons, both 
unaltered (left: arrowheads; right: arrow) and degenerating (right: arrowhead), as 
demonstrated in satellitosis. Microglial cells surrounding the neuron are also 
positive.Indirect peroxidase method (A-F), Vectastain® Elite ABC-Alkaline Phosphatase Kit 
(E, left); DAB (A-F), BC/P/NBT blue (E, left), Papanicolaou’s haematoxylin counterstain. 
Scale bars A-D, F left = 50 pm. E, F right = 20 pm.
(Scores for each marker recorded on upper right corner)
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Table 5.2 Semi-quantitative analysis of cellular markers in the brain of monkeys 
following Japanese Encephalitis Virus infection
Monkey No. Tissue PRO-INFAMMATORY Markers
iNOS NT TNF-a INF-a MM P-2 MM P-9
1 B 1 + 2+ 3+ 2+ 2+ 3+
T 1 + 3+ 3+ 1+ 1 + ±
2 B 2+ 2+ 2+ 3+ 2+ 3+
T 3+ 2+ 2+ 1 + 3+ 2+
3 B - ± 1+ 1 + 2+ -
T 1 + 1 + 2+ 1 + 3+ -
4 B 1 + 1 + 1 + 1 + 2+ 2+
T 1 + 1 + 1 + 1 + 2+ -
5 B 1 + - 2+ 3+ 2+ 3+
T 1 + 2+ 2+ 2+ 1 + -
6 B 1 + 2+ 2+ 3+ 1 + 3+
T 1 + 2+ 3+ 2+ 3+ 3+
7 B 1 + ± 3+ 1 + 2+ 1 +
T 1 + - 3+ 1 + 3+ 2+
8 B 2+ 2+ 3+ 2+ 3+ 3+
T 2+ 1 + 3+ 2+ 3+ 3+
9 B 1 + 3+ 3+ 1 + 3+ 3+
T - 1+ 1 + 1 + 3+ 2+
10 B 2+ 1+ 3+ 2+ 3+ 3+
T 1 + - 3+ 2+ 1 + 1 +
11 B - 2+ 2+ 1 + 2+ 3+
T 1 + ± 3+ ± 3+ 2+
12 B 1 + - 1 + 1 + 1 + -
T 2+ 1 + 2+ 1 + 2+ 1 +
Mean 1 + 1 + 2+ 2+ 2+ 2+
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Immunohistochemistry of cell markers tested on paraffin sections of brainstem and 
thalamus and the level of expression recorded as:
0 = no expression observed above the negative control 
1 + = occasional isolated positive cells 
2+ = a few nests of positive cells 
3+ = frequent positive ceils in most brain areas
MAC 387 = anti human myeloid/histiocyte antigen (reactive macrophage)
iNOS = Inducible nitric oxide synthase
NT = Nitrotyrosine
INF-a = Interferon alpha
TNF-a = Tumor necrosis factor alpha
MM P-2 = Matrix mettaloproteinase-2
MMP-9 = Matrix mettaIoproteinase-9
B = Brain stem
T = Thalamus
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CHAPTER 6
GENERAL DISCUSSIONS
This chapter aims to examine the possible role of BBB dysfunction and 
the pathways of neuroinflammatory networks in JE pathogenesis.
Loss of Blood Brain Barrier integrity in JE
In JE, impairment of the BBB is implicated by the widespread 
perivascular oedema (German et al., 2006). The BBB is both structural 
and functional, impeding and regulating the influx of most compounds 
from blood to brain. This barrier is composed of specialized endothelial 
cells, joined by tight junctions, on a basal lamina, surrounded by 
pericytes and astrocytic foot processes (Figure 6.1). Breach can occur 
because of damage of the endothelial lining by trauma, allergic or 
inflammatory lesions, or because of the release of vasoactive mediators.
Disruption of the integrity of the BBB represents the early event of 
inflammatory diseases of the CNS and is reported to be caused by pro- 
inflammatory cytokines, MMPs and ROS (Blamire etal., 2000; Paul et 
ai, 2003; Wang et a/., 2004; Yang et al.} 1999) which facilitates
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additional dissemination of the virus within the CNS. Half of the animals 
had widespread perivascular oedema indicative of extensive BBB 
leakage. This was well demonstrated by von Willebrand staining, 
particularly in animal number 2.
While most agree there is haematological spread in JE, it is not clear 
whether this spread is passive or involves viral replication in the 
vascular endothelium. More specifically, although the presence of JEV 
has been demonstrated in the vascular endothelial cells (Johnson etal., 
1995), the mechanism of invasion of the CNS is not clear. Electron 
microscopic examination showed no evidence of damage to the 
vasculature (Hase et al., 1990). It has been postulated that specifically 
sensitised T cells enter the brain and release certain cytokines which 
then attract the macrophages (Johnson, 1971). A Trojan horse’ theory 
for passage of flavivirus across the BBB has also been proposed, 
whereby JEV (Yang et al., 2004) and WNV (Verma et al., 2009) infiltrate 
the CNS. My study does not support the Trojan horse’ theory as viral 
antigen in the perivascular cell infiltrates and the perivascular 
macrophages are rare. The distribution of zona occludens (ZO) -1 and 
occludin, proteins critical for tight junction function, was not explored in 
this study. Although knowledge of the morphology and physiology of the
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BBB has come a long way, the role of inflammatory mediators which 
induce alteration and loss of integrity of BBB in JE is still unanswered 
and should be investigated.
Neurite
Figure 6.1 Structure of Blood Brain Barrier
Inflammatory network in JE
Based on my findings I postulate that infection of neurons by JEV 
triggers a network of inflammatory mediators (Benarkis et al., 2009). 
Through release of IFN-a, neurons activate microglial cells which, via 
release of cytokines such as TNF-a, activate astrocytes and endothelial 
cells. Together, these mediators contribute to BBB breakdown,
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leukocyte recruitment into the parenchyma and further neuronal 
apoptosis. Glial cell apoptosis should limit the extent of inflammation. 
However, the release of further mediators by infiltrating leukocytes, in 
particular macrophages, results in sustained glial and endothelial cell 
activation and further leukocyte recruitment, ultimately augmenting the 
inflammatory response and neuronal cell loss (Figure 6.2). Although the 
inflammatory response is intended to be protective, and presumably is 
so in cases which improve and recover, if uncontrolled it can contribute 
to disease progression in JE.
Flavivirus encephalitis
Flaviviruses such as JEV, TBEV, WNV and St. Louis encephalitis virus 
(SLEV) are some of the most important pathogens that cause fatal 
encephalitis in humans. The pathogenesis of flavivirus encephalitis and 
the cause of neuronal injury in vivo remains incompletely understood, 
especially concerning viral replication, CNS invasion and the nature of 
immune responses. There is a need for comparative studies between 
these different viruses. In many cases it appears that the immune 
response, while crucial to limiting viral spread to the brain, is also 
responsible for the pathogenesis (Turtle et al., 2012). The mouse model 
of WNV, a closely related neurotropic and intensively studied flavivirus,
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has yielded a significant understanding of WNV pathogenesis (Samuel 
& Diamond, 2006; Lim et al., 2011). How the neurotropic flaviviruses 
gain access to the CNS and the specific cell types involved remain 
controversial, but interactions at the BBB are probably critical. WNV and 
SLEV are observed to cross the BBB in correlation to the level and 
duration ofviraemia (Lim etal., 2011). Mass release of inflammatory 
factors including cytokines, might pave the way for CNS infections by 
compromising BBB-integrity. How much neuronal damage is attributed 
to direct viral cytopathology and how much is due to the inflammatory 
process is unknown; the WNV mouse model showed a fine balance 
between these two factors (Turtle et al., 2012). The role of T cells in 
flavivirus encephalitis is less clear. CD8+ T cells are reported to 
contribute to neuronal damage via the induction of bystander damage in 
a number of flaviviruses including WNV and TBEV (Sips et al., 2012). 
CD8+ T cells show a dual role for clearing virus and mediating 
immunopathology in WNV infection; recent research on JEV in a murine 
model suggested that they might be more pathogenic (Larena et al., 
2011). WNV has been demonstrated to produce caspase-3 dependent 
apoptosis following infection in mice although the different cell death 
pathways are not defined (Lim etal., 2011). WNV also supports the role 
of TNF-a in neuronal death as implicated in my study with JEV. The
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extent to which involvement of microglial cells and astrocytes 
contributes to WNV-induced pathology has never been fully investigated 
although reactive gliosis and infection of these cells are considered key 
pathogenic features. The role of the inflammatory process in 
pathogenesis of flaviviruses including JEV remains speculative and 
more studies need to be done for further evidence of this hypothesis.
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The difficulty in obtaining tissue samples from fatal human cases 
demonstrates the need for an animal model to study the pathogenesis 
of JE. Because the immune system of the rhesus macaque closely 
resembles that of humans, the macaque model provides a good system 
for studying JEV.
My thesis provides insight into the neuropathogenesis of JE. I 
have characterized the cellular infiltrates, type of cells infected by JEV, 
apoptosis and pro-inflammatory infiltrates within the CNS by 
immunohistology techniques and fulfilled my aims/hypotheses to 
demonstrate that:
1. the immune response in JEV contributes to neuronal death and 
pathogenesis of infection;
2. cell death of JEV-infected neurons is caspase-3 dependent;
3. the activation of microglial cells and astrocytes plays a role in the 
pathogenesis through the action of pro-inflammatory mediators.
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CONCLUSIONS
This thesis examined the possible causes of neuronal damage in JE in a 
macaque model and hopefully improved the understanding of the 
neuropathogenesis of this infection.
Despite some successes with formalin-inactivated vaccination, and the 
promise of the newiy evaluated vaccines, JE will likely remain an important 
public health problem. The enzootic nature of JEV means that the 2.8 
billion people living in affected areas will continue to be exposed to the 
virus. Thankfully only a small proportion of those infected develops 
disease, but we have little understanding of what determines severity and 
outcome of the infection.
The cascade of events that I have outlined for JE may also apply to other 
viral encephalitides. Currently there is no proven efficacious therapy for 
most viral infections of the CNS including JE. Novel strategies for treating 
viral CNS infections are urgently needed. My thesis suggests that neuronal 
apoptosis and glial activation are crucial steps in the pathogenesis of JE. 
My results imply that adjunctive therapy with inhibitors of caspases or
130
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targeted anti-inflammatory treatments might be a promising therapeutic 
approach for JE in the future. Pathophysiological research described in this 
thesis has suggested possible therapeutic avenues for JE. Even in the 
absence of specific antiviral drugs for JE, measures aimed at controlling 
the apoptosis and inflammation may improve the prognosis of this terrible 
disease.
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Only a handful of laboratories are involved in rigorous studies on JEV.
1. My detailed study on Chapter 5 describes the apoptosis pathways 
involved in JE. The results of my study suggest for the first time that JEV 
might simultaneously trigger, both directly and indirectly, the extrinsic 
apoptotic pathway in neurons and the intrinsic apoptotic pathway in 
microglia] cells. The role of apoptotic proteins like FAS, FAS-L, TNFR as 
well as caspase-independent pathways should be explored to guide the 
best strategies to limit neuronal damage in JE.
2. A limitation of my study is that only paraffin tissue was available. JE was 
labelled as a select agent soon after my PhD study started and I had no 
possibilities to study the detailed cytokine profile (both pro- and anti­
inflammatory) including gene expression because most of the cytokine 
antibodies as well as the mRNA expression work well only in fresh 
frozen tissues. This led to a change of scope for my PhD studies to 
focus only on the available cytokines that are reported to work on 
paraffin embedded tissues like TNF-a and IL-1(3. The role of TNF-a in 
the inflammatory network is studied in this thesis in Chapter 6. The next
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step would be to identify other pro- and anti-inflammatory cytokines and 
their role in the pathogenesis of JE on fresh tissues.
3. The results in Chapter 3 confirm that a number of animals exhibited BBS 
leakage in this study. Although alterations in vesicular transport and 
trans-endothelial support may contribute to the increased BBB 
permeability, defective BBB tight junctions are thought to be the most 
important process in CNS infections. Distribution of proteins critical for 
tight junction function like zona occludens (ZO)-1 and occludin should 
be explored.
4. The results from Chapter 3 and 6 confirm the earlier reports on 
contribution of microglia to neuronal death in JE. My study highlights 
that in addition to microglial cells, astrocytes are found to play an 
important role in the inflammatory cascade. Oligodendrocytes are 
reported to play a major role in some CNS infections. Their role in JE 
encephalitis should be studied.
5. The results in Chapters 3 and 4 shows that perivascular macrophages 
were involved - some are shown to be apoptotic and some as 
scavenger cells. Further studies are necessary to confirm the functional 
activity of the perivascular macrophages in JE encephalitis.
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6. It has been reported that neuronal death is primarily due to the 
inflammatory milieu. In addition to microglia the relative contribution of 
peripheral macrophages known to migrate into the CNS in JE should be 
studied. The species cross-reactivity information of commercially 
available antibodies limits the study of macaque tissues. The role of CTL 
and T-helper cells is not explored in this study due to lack of antibodies 
for monkey tissue sections. The exact role of CTLs in disease protection 
and recovery in JE is still unclear and should be evaluated.
7. Many informative studies can be done in animal models. For cultural 
reasons, obtaining autopsy material is difficult but the use of human 
pathogenic specimens is needed to investigate whether the animal 
observations have direct correlation to human disease.
8. Last, but not least, the study of apoptosis and the inflammatory 
response to JE was conducted on target areas like thalamus and 
brainstem and neocortex which is less affected, due to limitation of 
reagents. Thalamus and brainstem were shown previously in my original 
challenge study to be heavily infected by JEV and exhibited the most 
consistent histological changes. However less involved areas like the 
cerebellum and spinal cord should also be evaluated for the complete 
picture of neuropathogenesis in JE.
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Appendix 1
Figure A1.1 Staining with inflammatory cell markers in the thalamus of an uninfected 
control rhesus macaque show no positive immunostaining for (A) CD3, (B) CD20, (C) 
CD68, and (D) MHC class II. Scale bars = 50 pm.
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Figure A1.2 Staining with apoptosis related proteins in the thalamus of an uninfected 
control rhesus macaque show negligible reactions with (A) caspase-3, (B) caspase-8, (C) 
caspase-9, (D) Bcl-2 and (E) occasional weak neuronal staining with Bax. Scale bars = 50 
pm.
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Figure A1.3 Staining with pro-inflammatory mediators in the thalamus of an uninfected 
control rhesus macaque with (A) iNOS, (B) NT, (C) MMP-2, (D) MMP-9, (E) TNF-ct, (F) 
IFN-a show occasional weak neuronal staining with (A) iNOS, (D) MMP-9, (F) IFN-a and 
vascular staining with (E) TNF-a. Scale bars = 50 pm.
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APPENDIX 2
PUBLICATIONS ARISING FROM THIS WORK
Myint KS, Gibbons RV, Perng GC, Solomon T. Unravelling the 
neuropathogenesis of Japanese encephalitis. Trans R SocTrop Med Hyg 
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APPENDIX 3
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in the rhesus monkey challenge model, American Society of Tropical 
Medicine and Hygiene Meeting, 8-10 December 2008, New Orleans, US
Apoptosis and Phenotyping in Japanese encephalitis virus infected rhesus 
monkey challenge models, Joint International Tropical Medicine Meeting, 
13-14 October 2008, Bangkok, Thailand
Inflammation in Japanese encephalitis - too much of a good thing? 
Association of British Neurologists Meeting, 22-26 June 2009, Liverpool, 
UK
Astrocytosis in Japanese encephalitis, American Society of Tropical 
Medicine and Hygiene Meeting, 3-7 November 2010, Atlanta, US
Inflammatory network in a primate model of Japanese encephalitis, 
Eijkman Symposium, 8-10 November 2011, Jakarta, Indonesia
Inflammation in Japanese encephalitis - a double edged sword?, LBIG
166
Appendix
Retreat, 28-30 March 2012, Leek, UK
167
